Published Papers |
No. | Title URL, Journal, Vol( No), Start Page- End Page, Publication date, DOI
|
1 | Significant association between HLA‐B*35:01 and onset of drug‐induced liver injury caused by Kampo medicines in Japanese , Hepatology Research, 53( 5), 440- 449, Dec. 30, 2022, https://doi.org/10.1111/hepr.13874
|
2 | Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury. , Hepatology research : the official journal of the Japan Society of Hepatology, 52( 10), 882- 887, Jul. 14, 2022, https://doi.org/10.1111/hepr.13812
|
3 | Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy. , Clinical case reports, 10( 4), e05690- , Apr. 2022, https://doi.org/10.1002/ccr3.5690
|
4 | Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antivirals. , DEN open, 2( 1), e11- , Apr. 2022, https://doi.org/10.1002/deo2.11
|
5 | [Liver injury in patients with moderate II COVID-19 who received dexamethasone monotherapy]. , Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 119( 4), 332- 341, 2022, https://doi.org/10.11405/nisshoshi.119.332
|
6 | Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19. , World journal of gastroenterology, 27( 48), 8370- 8373, Dec. 28, 2021, https://doi.org/10.3748/wjg.v27.i48.8370
|
7 | Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy. , Clinical journal of gastroenterology, 14( 6), 1725- 1732, Dec. 2021, https://doi.org/10.1007/s12328-021-01524-1
|
8 | Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study. , Journal of gastroenterology, , , Nov. 18, 2021, https://doi.org/10.1007/s00535-021-01836-6
|
9 |
|
10 | The first reported case of Noonan syndrome complicated with hepatocellular carcinoma. , Clinical case reports, 9( 7), e04317- , Jul. 2021, https://doi.org/10.1002/ccr3.4317
|
11 |
|
12 | Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings. , Internal medicine (Tokyo, Japan), 60( 6), 873- 881, Mar. 15, 2021, https://doi.org/10.2169/internalmedicine.5891-20
|
13 | The development of broncho-biliary fistula after treatment for hepatocellular carcinoma: a report of two cases. , Clinical journal of gastroenterology, 14( 1), 229- 237, Feb. 2021, https://doi.org/10.1007/s12328-020-01264-8
|
14 | Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. , Hepatology research : the official journal of the Japan Society of Hepatology, 51( 1), 51- 61, Jan. 2021, https://doi.org/10.1111/hepr.13576
|
15 | Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites: A multicenter retrospective propensity score-matched cohort study , Acta Gastro-Enterologica Belgica, 84( 1), 57- 63, 2021,
|
16 | A change in the timing for starting systemic therapies for hepatocellular carcinoma: The comparison of sorafenib and lenvatinib as the first-line treatment , Acta Gastro-Enterologica Belgica, 84( 1), 65- 72, 2021,
|
17 | Usefulness of fibroscan-ast (Fast) score in japanese patients with non-alcoholic fatty liver disease: A single-center retrospective experience , Acta Hepatologica Japonica, 62( 7), 393- 402, 2021, https://doi.org/10.2957/kanzo.62.393
|
18 | Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately. , Internal medicine (Tokyo, Japan), 60( 19), 3061- 3070, 2021, https://doi.org/10.2169/internalmedicine.6591-20
|
19 | An autopsy case of primary jejunal pouch cancer which protruded from the abdominal wall 14 years after total gastrectomy for gastric cancer. , Clinical journal of gastroenterology, 13( 6), 1091- 1095, Dec. 2020, https://doi.org/10.1007/s12328-020-01177-6
|
20 | Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment. , Cancers, 12( 10), , Oct. 10, 2020, https://doi.org/10.3390/cancers12102906
|
21 | Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis. , Clinical journal of gastroenterology, 13( 5), 896- 901, Oct. 2020, https://doi.org/10.1007/s12328-020-01103-w
|
22 | Two elder cases of hepatocellular carcinoma adjacent to intrahepatic vessels successfully treated by carbon ion radiotherapy. , Clinical journal of gastroenterology, 13( 5), 920- 926, Oct. 2020, https://doi.org/10.1007/s12328-020-01151-2
|
23 | Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir. , Clinical journal of gastroenterology, , , Sep. 10, 2020, https://doi.org/10.1007/s12328-020-01229-x
|
24 |
|
25 | A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis , LIVER INTERNATIONAL, 40( 8), 1926- 1933, Aug. 2020, https://doi.org/10.1111/liv.14534
|
26 | Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling. , World journal of hepatology, 12( 7), 350- 362, Jul. 27, 2020, https://doi.org/10.4254/wjh.v12.i7.350
|
27 |
|
28 | Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis. , Hepatology (Baltimore, Md.), 70( 6), 2035- 2046, Dec. 2019, https://doi.org/10.1002/hep.30552
|
29 | Favorable outcome of retreatment by direct-acting antivirals for the hepatitis C patients with Daclatasvir plus Asunaprevir combination therapy failure. , Hepatology research : the official journal of the Japan Society of Hepatology, 50( 3), 303- 312, Nov. 2019, https://doi.org/10.1111/hepr.13462
|
30 | Analyses of objective response, progression-free survival and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. , Hepatology research : the official journal of the Japan Society of Hepatology, 50( 3), 382- 395, Nov. 2019, https://doi.org/10.1111/hepr.13460
|
31 | Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure. , Internal medicine (Tokyo, Japan), 58( 20), 2969- 2975, Oct. 15, 2019, https://doi.org/10.2169/internalmedicine.2982-19
|
32 | Successful prolonged treatment of glecaprevir/pibrentasvir for chronic hepatitis C patient with treatment failure after 8-week therapy: a case report. , Clinical journal of gastroenterology, 12( 6), 592- 597, Aug. 2019, https://doi.org/10.1007/s12328-019-01029-y
|
33 | Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients , Obesity Surgery, 29( 4), 1195- 1201, Apr. 15, 2019, https://doi.org/10.1007/s11695-018-03641-2
|
34 | Impact of the prognostic nutritional index on the survival of Japanese patients with hepatocellular carcinoma treated with sorafenib: A multicenter retrospective study , Internal Medicine, 58( 13), 1835- 1844, Jan. 1, 2019, https://doi.org/10.2169/internalmedicine.1594-18
|
35 | Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature , World Journal of Clinical Cases, 7( 9), 1043- 1052, Jan. 1, 2019, https://doi.org/10.12998/wjcc.v7.i9.1043
|
36 | β-hydroxy-β-methyl butyrate/L-arginine/L-glutamine supplementation for preventing hand-foot skin reaction in sorafenib for advanced hepatocellular carcinoma , In Vivo, 33( 1), 155- 161, Jan. 1, 2019, https://doi.org/10.21873/invivo.11452
|
37 | Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan. , Hepatology research : the official journal of the Japan Society of Hepatology, 49( 1), 105- 110, Jan. 2019, https://doi.org/10.1111/hepr.13288
|
38 | Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology , World Journal of Hepatology, 10( 12), 934- 943, Dec. 1, 2018, https://doi.org/10.4254/wjh.v10.i12.934
|
39 | A real-world clinical application of the combination therapy with glecaprevir/pibrentasvir to special population in chronic hepatitis C patients , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33, 444- 444, Nov. 2018,
|
40 | Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus. , World journal of gastroenterology, 24( 38), 4304- 4310, Oct. 2018, https://doi.org/10.3748/wjg.v24.i38.4304
|
41 | 難治性悪性リンパ腫患者における輸血関連E型肝炎(Transfusion-associated hepatitis E in a patient with refractory malignant lymphoma) , 日本輸血細胞治療学会誌, 64( 5), 655- 659, Oct. 2018,
|
42 | Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis. , Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 51( 2), 226- 235, Oct. 2018, https://doi.org/10.1016/j.dld.2018.10.008
|
43 | [Is Balloon-Occluded Transcatheter Arterial Chemoembolization Effective in Patients with Hepatocellular Carcinoma That Is Unresponsive to Conventional Transcatheter Arterial Chemoembolization ?] , Gan to kagaku ryoho. Cancer & chemotherapy, 45( 9), 1291- 1296, Sep. 2018,
|
44 | Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia. , Internal medicine (Tokyo, Japan), 57( 15), 2189- 2195, Aug. 2018, https://doi.org/10.2169/internalmedicine.9624-17
|
45 | CYP2D6遺伝子多型検査を経て酵素補充療法から基質合成抑制療法へ変更したゴーシェ病I型の1例 , 肝臓, 59( 5), 243- 251, May. 2018,
|
46 | Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection , Journal of Gastroenterology, 53( 5), 689- , Apr. 1, 2018, https://doi.org/10.1007/s00535-017-1409-z
|
47 | Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection , Journal of Gastroenterology, 53( 4), 566- 575, Apr. 1, 2018, https://doi.org/10.1007/s00535-017-1396-0
|
48 | Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis , Journal of Gastroenterology, 53( 4), 557- 565, Apr. 1, 2018, https://doi.org/10.1007/s00535-017-1391-5
|
49 | Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin , Hepatology Research, 48( 3), E347- E353, Feb. 1, 2018, https://doi.org/10.1111/hepr.12971
|
50 | Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection , Hepatology, 67( 2), 505- 513, Feb. 1, 2018, https://doi.org/10.1002/hep.29510
|
51 | Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study , Hepatology Research, 48( 2), 165- 175, Feb. 1, 2018, https://doi.org/10.1111/hepr.12912
|
52 | A patient with type I gaucher disease who switched from enzyme replacement therapy to substrate reduction therapy after having of CYP2D6 polymorphisms checked , Acta Hepatologica Japonica, 59, 243- 251, Jan. 1, 2018, https://doi.org/10.2957/kanzo.59.243
|
53 | The Risk of Hepatocellular Carcinoma is Increased in Hepatitis C Virus Patients Treated with Interferon-free Direct-acting Antiviral-based Therapy: True or False? , BJSTR, 4( 5), , 2018,
|
54 | Possible Improvement of Liver Steatosis Associated with Elevated Creatine Phosphokinase Level Due to Subclinical Hypothyroidism by Thyroid Hormone Replacement Therapy , Biomedical Journal of Scientific & Technical Research, 4( 1), 1-5.- , 2018, https://doi.org/10.26717/BJSTR.2018.04.000992
|
55 | Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia , INTERNAL MEDICINE, 57( 15), 2189- 2195, 2018, https://doi.org/10.2169/internalmedicine.9624-17
|
56 | Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C , HEPATOLOGY RESEARCH, 47( 12), 1346- 1353, Nov. 2017, https://doi.org/10.1111/hepr.12905
|
57 | Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients , ADVANCES IN THERAPY, 34( 6), 1449- 1465, Jun. 2017, https://doi.org/10.1007/s12325-017-0506-y
|
58 | Autochthonous sporadic acute hepatitis E caused by two distinct subgenotype 3b hepatitis E virus strains with only 90% nucleotide identity , Clinical Journal of Gastroenterology, 10( 2), 168- 173, Apr. 1, 2017, https://doi.org/10.1007/s12328-017-0718-3
|
59 | Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015 , HEPATOLOGY RESEARCH, 47( 5), 435- 445, Apr. 2017, https://doi.org/10.1111/hepr.12765
|
60 |
|
61 |
|
62 | Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study , TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 241( 1), 45- 53, Jan. 2017, https://doi.org/10.1620/tjem.241.45
|
63 | Daclatasvir・asunaprevir併用療法中にワルファリンカリウムの効果減弱を来した大動脈解離術後のC型慢性肝炎の一例 , 肝臓, 58( 1), 22- 27, Jan. 2017,
|
64 | Minimizing the effect of warfarin potassium during daclatasvir/asunaprevir combination therapy in a case of chronic hepatitis C after aortic dissection , Acta Hepatologica Japonica, 58( 1), 22- 27, 2017, https://doi.org/10.2957/kanzo.58.22
|
65 | Association between skeletal muscle depletion and sorafenib treatment in male patients with hepatocellular carcinoma: A retrospective cohort study , Acta Medica Okayama, 71( 4), 291- 299, 2017, https://doi.org/10.18926/AMO/55305
|
66 |
|
67 |
|
68 | Spontaneous regression of methotrexate-related diffuse large B-cell lymphoma following bladder lesion resection. , [Rinsho ketsueki] The Japanese journal of clinical hematology, 58( 4), 287- 291, 2017, https://doi.org/10.11406/rinketsu.58.287
|
69 |
|
70 | Isolated Gastric Varices Refractory to Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Successfully Treated by Shunt-occluded Endoscopic Injection Sclerotherapy (SO-EIS): A Case Report and Review of the Literature , INTERNAL MEDICINE, 56( 9), 1041- 1048, 2017, https://doi.org/10.2169/internalmedicine.56.7761
|
71 | Therapy with ombitasvir/paritaprevir/ritonavir for dialysis patients with hepatitis C , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, 377- 377, Nov. 2016,
|
72 | [A Case of Transfusion-transmitted Acute Hepatitis E]. , Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 105( 11), 2215- 2220, Nov. 2016,
|
73 | A case of bleeding gastric varices with bacteremia after injection of N-butyl-2-cyanoacrylate successfully treated with balloon-occluded retrograde transvenous obliteration , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, 404- 405, Nov. 2016,
|
74 | Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy , COLORECTAL DISEASE, 18( 7), 696- 702, Jul. 2016, https://doi.org/10.1111/codi.13258
|
75 | Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations , Clinical Journal of Gastroenterology, 9( 3), 160- 167, Jun. 1, 2016, https://doi.org/10.1007/s12328-016-0649-4
|
76 | A case of idiopathic portal hypertension associated with nodular regenerative hyperplasia-like nodule of the liver and mixed connective tissue disease , Journal of Japanese Society of Gastroenterology, 113( 5), 828- 835, May. 1, 2016, https://doi.org/10.11405/nisshoshi.113.828
|
77 |
|
78 | Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus , WORLD JOURNAL OF CLINICAL CASES, 4( 3), 88- 93, Mar. 2016, https://doi.org/10.12998/wjcc.v4.i3.88
|
79 | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery , JOURNAL OF GASTROENTEROLOGY, 51( 3), 281- 289, Mar. 2016, https://doi.org/10.1007/s00535-015-1114-8
|
80 | Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation , Clinical Journal of Gastroenterology, 9( 1), 27- 31, Feb. 1, 2016, https://doi.org/10.1007/s12328-016-0626-y
|
81 |
|
82 | Early Decreases in alpha-Fetoprotein and Des-gamma-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma , INTERNAL MEDICINE, 55( 16), 2163- 2171, 2016, https://doi.org/10.2169/internalmedicine.55.6688
|
83 | Analysis erythrocyte elements in chronic hepatitis C patients receiving pegIFN monotherapy, dual therapy, and triple therapy using in-air microPIXE. , The Kitakanto Medical Journal, 66( 2), 91- 102, 2016, https://doi.org/10.2974/kmj.66.91
|
84 | A case of chronic hepatitis c accompanied by marked thrombocytopenia during combination therapy with daclatasvir and asunaprevir , Acta Hepatologica Japonica, 56( 11), 603- 609, Dec. 4, 2015, https://doi.org/10.2957/kanzo.56.603
|
85 | Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 377- 378, Dec. 2015,
|
86 | Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir , WORLD JOURNAL OF CLINICAL CASES, 3( 12), 1005- 1010, Dec. 2015, https://doi.org/10.12998/wjcc.v3.i12.1005
|
87 | 両下肢の壊疽性膿皮症を合併した潰瘍性大腸炎の1例 , Progress of Digestive Endoscopy, 87( 1), 186,16- 187,16, Dec. 2015,
|
88 | A case of endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 308- 308, Dec. 2015,
|
89 | Malignant peripheral nerve sheath tumor of the liver , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 331- , Dec. 2015,
|
90 |
|
91 | Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis , HEPATOLOGY, 62( 4), 1037- 1046, Oct. 2015, https://doi.org/10.1002/hep.27972
|
92 | Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma , HEPATOLOGY RESEARCH, 45( 9), 1014- 1022, Sep. 2015, https://doi.org/10.1111/hepr.12431
|
93 | The relationship between renin angiotensin system inhibitor and serum potassium increase during combination therapy with daclatasvir and asnaplevir for chronic hepatitis C , Acta Hepatologica Japonica, 56( 7), 324- 331, Jul. 29, 2015, https://doi.org/10.2957/kanzo.56.324
|
94 | Full Genome Analysis of a European-Type Genotype 3 Hepatitis E Virus Variant Obtained From a Japanese Patient With Autochthonous Acute Hepatitis E , JOURNAL OF MEDICAL VIROLOGY, 87( 7), 1067- 1071, Jul. 2015, https://doi.org/10.1002/jmv.24191
|
95 | Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan , HEPATOLOGY RESEARCH, 45( 7), 745- 754, Jul. 2015, https://doi.org/10.1111/hepr.12416
|
96 | Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? Response , AMERICAN JOURNAL OF GASTROENTEROLOGY, 110( 7), 1086- 1087, Jul. 2015, https://doi.org/10.1038/ajg.2015.166
|
97 | Percutaneous radiofrequency ablation for hepatocellular carcinoma located in the caudate lobe of the liver , ACTA GASTRO-ENTEROLOGICA BELGICA, 78( 3), 267- 273, Jul. 2015,
|
98 | Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma , HEPATOLOGY RESEARCH, 45( 6), 663- 666, Jun. 2015, https://doi.org/10.1111/hepr.12403
|
99 | Randomized Trial of Interferon- and Ribavirin-Free Ombitasvir/Paritaprevir/Ritonavir in Treatment-Experienced Hepatitis C Virus-Infected Patients , HEPATOLOGY, 61( 5), 1523- 1532, May. 2015, https://doi.org/10.1002/hep.27705
|
100 | More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy , JOURNAL OF GASTROENTEROLOGY, 50( 3), 298- 304, Mar. 2015, https://doi.org/10.1007/s00535-014-0972-9
|
101 | A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia , AMERICAN JOURNAL OF GASTROENTEROLOGY, 110( 3), 423- 431, Mar. 2015, https://doi.org/10.1038/ajg.2015.20
|
102 | A Prospective Randomized Controlled Study of Endoscopic Sphincterotomy With the Endocut Mode or Conventional Blended Cut Mode , JOURNAL OF CLINICAL GASTROENTEROLOGY, 49( 2), 127- 131, Feb. 2015, https://doi.org/10.1097/MCG.0000000000000096
|
103 | Drug-induced liver injury caused by a dietary supplement (Kin-toki Shoga®) made from ginger , Journal of Japanese Society of Gastroenterology, 112( 1), 108- 114, Jan. 1, 2015, https://doi.org/10.11405/nisshoshi.112.108
|
104 | サプリメント(金時しょうが)による薬物性肝障害の1例 , 日本消化器病学会雑誌, 112( 1), 108- 114, Jan. 2015,
|
105 | A Prospective Randomized Controlled Trial of AJG522 versus Standard PEG plus E as Bowel Preparation for Colonoscopy , Biomed Research International, 2015, 521756- , 2015, https://doi.org/10.1155/2015/521756
|
106 |
|
107 |
|
108 | マウスアルコール性脂肪性肝炎モデルにおける細胞特異的なSTAT3の役割 , アルコールと医学生物学, 32, 9- 11, Jan. 2014,
|
109 | A case of Budd-Chiari syndrome that died of hepatic failure by gradual thromboses of hepatic veins , Acta Hepatologica Japonica, 55( 10), 612- 618, 2014, https://doi.org/10.2957/kanzo.55.612
|
110 | 当科および関連施設における小腸内視鏡診断・治療の現況 , Progress of Digestive Endoscopy, 83( 1), 60- 64, Dec. 2013,
|
111 | Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot "Prunus mume " , World Journal of Hepatology, 5( 10), 596- 600, Oct. 2013, https://doi.org/10.4254/wjh.v5.i10.596
|
112 |
|
113 | Transforming growth factor-alpha activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation , LABORATORY INVESTIGATION, 93( 6), 720- 732, Jun. 2013, https://doi.org/10.1038/labinvest.2013.59
|
114 | ヒト胆管細胞癌株におけるgefitinib・gemcitabine併用療法の有用性に関する検討 , 肝臓, 54( Suppl.1), A136- A136, Apr. 2013,
|
115 | Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28( 4), 690- 699, Apr. 2013, https://doi.org/10.1111/jgh.12118
|
116 | 超高齢者肝細胞癌に重粒子線治療を行うも、その後短期間のうちに肝内および肺転移をきたした1例 , Personalized Medicine Universe. Japanese Edition, 1( 1), 42- 45, Jan. 2013,
|
117 | A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts , Acta Medica Okayama, 67( 1), 45- 53, 2013, https://doi.org/10.18926/AMO/49256
|
118 | Spleen stiffness correlates with the presence of ascites but not esophageal varices in chronic hepatitis C patients , BioMed Research International, 2013, 857862- , 2013, https://doi.org/10.1155/2013/857862
|
119 | Incidence, Mortality, and Predictive Factors of Hepatocellular Carcinoma in Primary Biliary Cirrhosis , GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 168012- , 2013, https://doi.org/10.1155/2013/168012
|
120 | Gefitinib and Gemcitabine Coordinately Inhibited the Proliferation of Cholangiocarcinoma Cells , ANTICANCER RESEARCH, 32( 12), 5251- 5262, Dec. 2012,
|
121 | A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk factors: Successful treatment with argon plasma coagulation , Clinical Journal of Gastroenterology, 5( 5), 336- 340, Oct. 2012, https://doi.org/10.1007/s12328-012-0329-y
|
122 |
|
123 |
|
124 | 【クリティカルケアに必要な糖代謝と栄養管理-SCCM/ASPEN栄養管理ガイドラインに準拠して-】高血糖の急性毒性 肝臓における高血糖の急性毒性 , 救急・集中治療, 24( 5-6), 540- 544, Jun. 2012,
|
125 | Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis , HEPATOLOGY INTERNATIONAL, 6( 3), 620- 630, Jun. 2012, https://doi.org/10.1007/s12072-011-9301-z
|
126 | Ligand Dependent Hepatic Gene Expression Profiles of Nuclear Receptors Car and PXR , GASTROENTEROLOGY, 142( 5), S988- , May. 2012,
|
127 | 【C型肝炎治療の新たな展開】Genotype 2かつ高ウイルス量C型慢性肝炎に対するResponse-Guided Therapy , 消化器内科, 54( 4), 478- 485, Apr. 2012,
|
128 |
|
129 | Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 27( 1), 69- 75, Jan. 2012, https://doi.org/10.1111/j.1440-1746.2011.06802.x
|
130 |
|
131 | A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia , JOURNAL OF GASTROENTEROLOGY, 46( 8), 1010- 1019, Aug. 2011, https://doi.org/10.1007/s00535-011-0407-9
|
132 | 治療前よりEGFRチロシンキナーゼ阻害薬治療耐性遺伝子変異を有し、急激な経過で死亡した若年性肺腺癌の1例 , 日本内科学会雑誌, 100( 7), 1959- 1962, Jul. 2011,
|
133 | 乳癌術後13年目に食道気管瘻で発症した転移性食道癌と原発性横行結腸癌の重複癌を認めた1例 , The Kitakanto Medical Journal, 61( 2), 263- 264, May. 2011,
|
134 | 群馬県における肝炎医療費助成の現状と問題点 , 肝臓, 52( 5), 287- 294, May. 2011,
|
135 |
|
136 |
|
137 | Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. , , , , 2011,
|
138 |
|
139 | Histone Deacetylase Inhibitors Induce Cytochrome P450 2B by Activating Nuclear Receptor Constitutive Androstane Receptor , DRUG METABOLISM AND DISPOSITION, 38( 9), 1493- 1498, Sep. 2010, https://doi.org/10.1124/dmd.110.032854
|
140 | 麻痺性イレウスにより発症し、成人型Hirschsprung病様の所見を呈した直腸サルコイドーシスの1例 , The Kitakanto Medical Journal, 60( 3), 281- 281, Aug. 2010,
|
141 |
|
142 | Clinical characteristics of null responders to peg-IFNα2b/ribavirin therapy for chronic hepatitis C , World Journal of Hepatology, 2( 11), 401- 405, 2010, https://doi.org/10.4254/wjh.v2.i11.401
|
143 |
|
144 |
|
145 | プレドニゾロンのジェネリック医薬品への変更により増悪した自己免疫性肝炎の1例 , 日本消化器病学会雑誌, 106( 10), 1488- 1493, Oct. 2009,
|
146 |
|
147 | A case of autoimmune hepatitis which worsened after switching from a brand name to a generic version of prednisolone , Journal of Japanese Society of Gastroenterology, 106( 10), 1488- 1493, Oct. 2009, https://doi.org/10.11405/nisshoshi.106.1488
|
148 | Usefulness of Radiofrequency Ablation with Micro-Convex Probe for Hepatocellular Carcinoma , HEPATO-GASTROENTEROLOGY, 56( 93), 1127- 1132, Jul. 2009,
|
149 | Low burden of a JAK2-V617F mutated clone in monoclonal haematopoiesis in a Japanese woman with Budd-Chiari syndrome , INTERNATIONAL JOURNAL OF HEMATOLOGY, 89( 4), 517- 522, May. 2009, https://doi.org/10.1007/s12185-009-0280-y
|
150 |
|
151 | 【NASH起因発癌のエビデンス】NASH起因発癌におけるリスクファクター , 消化器科, 48( 1), 88- 96, Jan. 2009,
|
152 | A case of liver cancer progressed rapidly with the change of enhanced - Pattern after percutaneous radiofrequency ablation , Acta Hepatologica Japonica, 50( 2), 84- 89, 2009, https://doi.org/10.2957/kanzo.50.84
|
153 |
|
154 |
|
155 | 【C型肝炎のすべて・2009】合併症を有する患者のHCV治療 血小板低値C型肝炎に対するPSE+IFN療法 , 肝・胆・膵, 57( 5), 959- 967, Nov. 2008,
|
156 | Non alcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients , GASTROENTEROLOGY, 134( 4), A370- A371, Apr. 2008, https://doi.org/10.1007/s00535-007-2130-0
|
157 |
|
158 | Severe liver dysfunction due to bosentan in a patient with mixed connective tissue disease , EUROPEAN JOURNAL OF DERMATOLOGY, 18( 2), 190- 191, Mar. 2008, https://doi.org/10.1684/ejd.2008.0361
|
159 |
|
160 |
|
161 |
|
162 |
|
163 |
|
164 |
|
165 | Nonalcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients , JOURNAL OF GASTROENTEROLOGY, 43( 1), 86- 92, 2008, https://doi.org/10.1007/s00535-007-2130-0
|
166 | Ectopic varices rupture in the gastroduodenal anastomosis successfully treated with N-butyl-2-cyanoacrylate injection , ACTA MEDICA OKAYAMA, 61( 6), 361- 365, Dec. 2007, https://doi.org/10.18926/AMO/32880
|
167 | Hepatocellular carcinoma with portal vein tumor thrombosis: Clinical characteristics, prognosis, and patient survival analysis , DIGESTIVE DISEASES AND SCIENCES, 52( 11), 3290- 3295, Nov. 2007, https://doi.org/10.1007/s10620-007-9808-2
|
168 | Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma , HEPATO-GASTROENTEROLOGY, 54( 79), 2073- 2077, Oct. 2007,
|
169 |
|
170 |
|
171 | Small pancreatic lipoma: Case report and literature review , HEPATO-GASTROENTEROLOGY, 54( 77), 1582- 1584, Jul. 2007,
|
172 |
|
173 |
|
174 |
|
175 | [Chronic eosinophilic leukemia with symptoms resembling Budd-Chiari syndrome due to liver infiltration]. , [Rinsho ketsueki] The Japanese journal of clinical hematology, 48( 6), 505- 509, Jun. 2007, https://doi.org/10.11406/rinketsu.48.505
|
176 | Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 22( 4), 518- 522, Apr. 2007, https://doi.org/10.1111/j.1440-1746.2007.04844.x
|
177 | Hepatocellular carcinoma in young adults: The clinical characteristics, prognosis, and findings of a patient survival analysis , DIGESTIVE DISEASES AND SCIENCES, 52( 4), 1103- 1107, Apr. 2007, https://doi.org/10.1007/s10620-006-9578-2
|
178 |
|
179 |
|
180 | 【本邦における非B非C肝癌の実態】HBV,HCVを除く各種慢性肝疾患における肝発癌の臨床的特徴 NAFLD/NASH , 肝・胆・膵, 54( 3), 339- 348, Mar. 2007,
|
181 |
|
182 | Health related quality of life in patients with primary biliary cirrhosis using a Japanese version of the PBC-40 questionnaire , Acta Hepatologica Japonica, 48( 6), 256- 263, 2007, https://doi.org/10.2957/kanzo.48.256
|
183 |
|
184 | Health related quality of life in patients with primary biliary cirrhosis using a Japanese version of the PBC-40 questionnaire , Acta Hepatologica Japonica, 48( 6), 256- 263, 2007, https://doi.org/10.2957/kanzo.48.256
|
185 | Possible role for human leukocyte antigen haplotype in rofecoxib-associated acute pancreatitis and cholestatic hepatitis , CLINICAL PHARMACOLOGY & THERAPEUTICS, 80( 5), 554- 555, Nov. 2006, https://doi.org/10.1016/j.clpt.2006.08.007
|
186 |
|
187 | Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B (vol 41, pg 283, 2006) , JOURNAL OF GASTROENTEROLOGY, 41( 9), 927- 927, Sep. 2006, https://doi.org/10.1007/s00535-006-1956-1
|
188 |
|
189 | Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury , BMC GASTROENTEROLOGY, 6, 22- , Aug. 2006, https://doi.org/10.1186/1471-230X-6-22
|
190 | Solitary mandibular metastasis as an initial manifestation of hepatocellular carcinoma , ACTA MEDICA OKAYAMA, 60( 4), 243- 247, Aug. 2006, https://doi.org/10.18926/AMO/30713
|
191 | 【B型慢性肝炎の治療方針の再検討 長期寛解をめざして】Lamivudine(LAM)耐性株が出現したB型慢性肝疾患に対するAdefovir dipivoxil(ADV)単独療法の有用性 , 消化器科, 42( 4), 384- 389, Apr. 2006,
|
192 | Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: Case report and literature review , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 10), 1645- 1648, Mar. 2006, https://doi.org/10.3748/wjg.v12.i10.1645
|
193 | Living-related liver transplantation for multiple liver metastases from rectal carcinoid tumor: A case report , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 11), 1805- 1809, Mar. 2006, https://doi.org/10.3748/wjg.v12.i11.1805
|
194 | The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia , TRANSPLANT INTERNATIONAL, 19( 3), 255- 257, Mar. 2006, https://doi.org/10.1111/j.1432-2277.2006.00263.x
|
195 | Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B , JOURNAL OF GASTROENTEROLOGY, 41( 3), 283- 285, Mar. 2006, https://doi.org/10.1007/s00535-006-1770-9
|
196 | Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: A randomized controlled clinical trial , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 8), 1265- 1269, Feb. 2006, https://doi.org/10.3748/wjg.v12.i8.1265
|
197 | Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2 , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 6), 945- 950, Feb. 2006, https://doi.org/10.3748/wjg.v12.i6.945
|
198 |
|
199 | Different outcomes of nosocomial infection with hepatitis C virus from the same origin , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 4), 659- 661, Jan. 2006, https://doi.org/10.3748/wjg.v12.i4.659
|
200 | Hepatocellular carcinoma in extremely elderly patients: An analysis of clinical characteristics, prognosis and patient survival , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 1), 48- 53, Jan. 2006, https://doi.org/10.3748/wjg.v12.i1.48
|
201 | Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome , WORLD JOURNAL OF GASTROENTEROLOGY, 12( 4), 608- 611, Jan. 2006, https://doi.org/10.3748/wjg.v12.i4.608
|
202 |
|
203 |
|
204 |
|
205 |
|
206 | A younger male patient with pulmonary large cell neuroendocrine carcinoma complicating with hemangioblastoma of the brain stem , Japanese Journal of Chest Diseases, 64, 740- 746, Sep. 1, 2005,
|
207 | [Hepatic metastasis from choroidal malignant melanoma developing 15 years after enucleation]. , Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 102( 9), 1201- 1206, Sep. 2005, https://doi.org/10.11405/nisshoshi.102.1201
|
208 |
|
209 |
|
210 | A case of pleomorphic carcinoma of the lung that responded well to chemotherapy with cisplatin and vinorelbine , Japanese Journal of Chest Diseases, 64, 173- 178, Mar. 29, 2005,
|
211 |
|
212 |
|
213 | Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interaction with p53, actin and p56(Ick) , PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101( 39), 14079- 14084, Sep. 2004, https://doi.org/10.1073/pnas.0406040101
|
214 |
|
215 | A phage display selection of engrailed homeodomain mutants and the importance of residue Q50 , NUCLEIC ACIDS RESEARCH, 32( 12), 3623- 3631, Jul. 2004, https://doi.org/10.1093/nar/gkh690
|
216 |
|
217 |
|
218 | Pilot Clinical Trial of the Use of Alpha-tocopherol for the Prevention of Hepatocellular Carcinoma in Patients with Liver Cirrhosis , International Journal for Vitamin and Nutrition Research, 73( 6), 411- 415, 2003, https://doi.org/10.1024/0300-9831.73.6.411
|
219 |
|
220 |
|
221 |
|
222 | A ligand for peroxisome proliferator activated receptor γ Inhibits cell growth and induces apoptosis in human liver cancer cells , Gut, 50( 4), 563- 567, 2002, https://doi.org/10.1136/gut.50.4.563
|
223 |
|
224 | 展開型電極を用いた経皮的ラジオ波熱凝固療法による原発性及び転移性肝癌の治療 , The Kitakanto Medical Journal, 51( 2), 129- 134, Mar. 2001,
|
225 |
|
226 | Percutaneous radiofrequency ablation for primary and metastatic liver cancers by an expandable electrode , Kitakanto Medical Journal, 51( 2), 129- 134, 2001, https://doi.org/10.2974/kmj.51.129
|
227 | Effect of alpha-tocopherol on hepatocarcinogenesisi in transforming growth factor-alpha(TGF-alpha) transgenic mice treated with diethInitrosamine. , IntJ Vitam Nutr Res, 71, 268- 273, 2001,
|
228 | Effect of α-tocopherol on hepatocarcinogenesis in transforming growth factor-α (TGF-α) transgenic mice treated with diethylnitrosamine , International Journal for Vitamin and Nutrition Research, 71( 5), 261- 267, 2001, https://doi.org/10.1024/0300-9831.71.5.261
|
229 | A Case of Legionnaires' Pneumonia Associated with Rhabdomyolysis and Recurrent Gastrointestinal Bleeding , Japanese Journal of Chest Diseases, 59, 280- 281, Dec. 1, 2000,
|
230 | 生体におけるマイクロ波及びラジオ波の凝固効果の検討 , The Kitakanto Medical Journal, 50( 6), 517- 522, Oct. 2000,
|
231 | 横紋筋融解症による急性腎不全,消化管出血をきたしたレジオネラ肺炎の1例 , 日本胸部臨床, 59( 4), 276- 281, Apr. 2000,
|
232 | Analysis of the coagulation effect of microwave coagulation therapy and radiofrequency ablation , Kitakanto Medical Journal, 50巻6号 Page517-522( 6), 517- 522, Jan. 1, 2000, https://doi.org/10.2974/kmj.50.517
|
233 |
|
234 |
|
235 |
|
236 | A Case of Hepatocellular Carcinoma with Adrenal Metastasis Complicated by Delayed-Type Hemolytic Anemia after Transfusion Following Transcatheter Arterial Embolization. , The KITAKANTO Medical Journal, 50巻4号 Page381-387( 4), 381- 387, 2000, https://doi.org/10.2974/kmj.50.381
|
237 | Prevalence of hepatitis G virus in liver disease , CANADIAN JOURNAL OF GASTROENTEROLOGY, 13( 10), 823- 826, Dec. 1999,
|
238 | Faropenem enhances superoxide anion production by human neutrophils in vitro , JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 44( 3), 337- 341, Sep. 1999, https://doi.org/10.1093/jac/44.3.337
|
239 |
|
240 | C型慢性肝炎に対する高用量Interferonα-2b(イントロンA)の治療効果 , 診療と新薬, 35( 7), 651- 658, Jul. 1998,
|
241 | Accidental transmission of HCV and treatment with interferon , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 13( 3), 238- 243, Mar. 1998,
|
242 | Effect of epalrestat, an aldose reductase inhibitor, on the generation of oxygen-derived free radicals in neutrophils from streptozotocin-induced diabetic rats , Endocrinology, 139( 8), 3404- 3408, 1998, https://doi.org/10.1210/endo.139.8.6152
|
243 | A CASE OF ACQUIRED IMMUNODEFICIENCY SYNDROME ASSOCIATED WITH FULMINANT HEPATITIS AND NON HODGKIN LYMPHOMA , The Kitakanto Medical Journal, 44( 4), 421- 427, 1994, https://doi.org/10.2974/kmj1951.44.421
|
244 | IFN・UDCA併用療法が有効であったC型慢性肝炎合併原発性胆汁性肝硬変症の1例 , 日本消化器病学会雑誌, 90( 9), 2152- 2156, Sep. 1993,
|
245 | A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid. , Nippon Shokakibyo Gakkai Zasshi, 90( 9), 2152- 2156, 1993, https://doi.org/10.11405/nisshoshi1964.90.2152
|
246 |
|
MISC |
No. | Title URL, Journal, Vol( No), Start Page- End Page, Publication date
|
1 | A retrospective analysis of pembrolizumab in patients with high microsatellite instability cholangiocarcinoma , ANNALS OF ONCOLOGY, 33, S518- S518, Jul. 2022
|
2 | Characteristics of cases of hepatitis E in Gunma prefecture: Small epidemics caused by the same subgenotype 3a strains , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 36, 87- 88, Aug. 2021
|
3 | ERCP with a rotary papillotome was facilitated by adjusting monitor position in a patient with situs inversus totalis , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 36, 88- 89, Aug. 2021
|
4 | SIRT1 SIGNALING MAY BE INVOLVED IN ATTENUATION OF LIVER STEATOSIS BY THE SGLT2 INHIBITOR IPRAGLIFLOZIN , HEPATOLOGY, 70, 1323A- 1323A, Oct. 2019
|
5 | NBNC肝癌の臨床病理学的検討 , 肝臓, 60( Suppl.2), A707- A707, Oct. 2019
|
6 | レンバチニブの至適導入タイミングとは? , 肝臓, 60( Suppl.2), A704- A704, Oct. 2019
|
7 | LONG-TERM RESULTS OF BARIATRIC SURGERY FOR NON-ALCOHOLIC FATTY LIVER DISEASE/NON-ALCOHOLIC STEATOHEPATITIS TREATMENT IN MORBIDLY OBESE JAPANESE PATIENTS , GASTROENTEROLOGY, 156( 6), S1298- S1298, May. 2019
|
8 | DRUG INDUCED LIVER INJURY DUE TO IMMUNE CHECKPOINT BLOCKADES IN JAPAN , GASTROENTEROLOGY, 156( 6), S1315- S1315, May. 2019
|
9 | ダクラタスビル・アスナプレビル併用療法不成功例におけるDAAs再治療例の検討 , 肝臓, 60( Suppl.1), A328- A328, Apr. 2019
|
10 | ペムブロリズマブによる急性肝不全非昏睡型の一例 , 肝臓, 60( Suppl.1), A312- A312, Apr. 2019
|
11 | ニボルマブ投与で好酸球増多と下垂体機能低下を来した術後再発胃癌の1例 , 日本消化器病学会関東支部例会プログラム・抄録集, 354回, 28- 28, Apr. 2019
|
12 | レンバチニブの初期治療経験 , 日本消化器病学会雑誌, 116( 臨増総会), A414- A414, Mar. 2019
|
13 | C型慢性肝炎難治例に対するDAA再治療の検討 , 日本消化器病学会雑誌, 116( 臨増総会), A311- A311, Mar. 2019
|
14 | DAAs治療によるSVR後の肝発癌 , 日本消化器病学会雑誌, 116( 臨増総会), A334- A334, Mar. 2019
|
15 | HER2陽性胆道癌についての探索的研究 , 日本消化器病学会雑誌, 116( 臨増総会), A366- A366, Mar. 2019
|
16 | 当院における肝細胞癌腹腔内破裂症例の検討 , 日本消化器病学会雑誌, 116( 臨増総会), A376- A376, Mar. 2019
|
17 | 当院における肝臓病教室・患者サロンの現状 , 日本消化器病学会雑誌, 116( 臨増総会), A458- A458, Mar. 2019
|
18 | 高度黄疸を来した多中心性キャッスルマン病の1例 , 日本消化器病学会関東支部例会プログラム・抄録集, 353回, 46- 46, Feb. 2019
|
19 | 局所製剤未使用にも関わらず再燃時に直腸に炎症を認めなかった潰瘍性大腸炎の1例 , Progress of Digestive Endoscopy, 94( Suppl.), s136- s136, Dec. 2018
|
20 | ベトナムで感染した肝蛭症に対してプラジカンテルが奏功した一例 , 肝臓, 59( Suppl.3), A988- A988, Nov. 2018
|
21 | アルコール性肝硬変に合併した被嚢性腹膜硬化症の1例 , 肝臓, 59( Suppl.3), A936- A936, Nov. 2018
|
22 | DAA治療不成功例に対するDAAによるサルベージ治療戦略 , 肝臓, 59( Suppl.3), A937- A937, Nov. 2018
|
23 | C型慢性肝炎DAA再治療例の検討 , 肝臓, 59( Suppl.3), A937- A937, Nov. 2018
|
24 | 後期高齢者慢性C型肝炎に対するDAAs治療 , 肝臓, 59( Suppl.3), A944- A944, Nov. 2018
|
25 | 指状嵌入樹状細胞肉腫浸潤による急性肝不全の一例 , 肝臓, 59( Suppl.3), A992- A992, Nov. 2018
|
26 | 神経性食思不振症に合併した多発肝腫瘤の二例 , 日本消化器病学会雑誌, 115( 臨増大会), A802- A802, Oct. 2018
|
27 | NAFLD/NASHモデルにおけるマクロファージ遊走阻止因子(MIF)の役割 , 日本消化器病学会雑誌, 115( 臨増大会), A740- A740, Oct. 2018
|
28 | 当院での肝細胞癌におけるALBI gradeの有用性 , 日本消化器病学会雑誌, 115( 臨増大会), A802- A802, Oct. 2018
|
29 | 当院におけるB型肝癌と潜在性B型肝癌 , 肝臓, 59( Suppl.2), A659- A659, Sep. 2018
|
30 | 前治療Conventional Transcatheter Arterial Chemoembolization(C-TACE)に反応しない肝細胞癌症例に対してBalloon-Occluded Transcatheter Arterial Chemoembolization(B-TACE)は有効か? , 癌と化学療法, 45( 9), 1291- 1296, Sep. 2018
|
31 | 肝細胞癌に対するダブルプラチナ療法の効果予測因子についての検討 , 肝臓, 59( Suppl.2), A687- A687, Sep. 2018
|
32 | アルコール性およびNASH関連肝細胞癌の臨床的特徴および予後の検討 , 肝臓, 59( Suppl.2), A694- A694, Sep. 2018
|
33 | 肝性脳症に対するリファキシミンの治療効果と認容性 多施設93例の検討 , 肝臓, 59( Suppl.2), A722- A722, Sep. 2018
|
34 | ルストロンボパグの反復投与における有効性と安全性の検討 , 肝臓, 59( Suppl.2), A726- A726, Sep. 2018
|
35 | 門脈-大循環分流術において上腸間膜静脈のバルーン閉塞による血流コントロールが有効であった一例 , 日本門脈圧亢進症学会雑誌, 24( 3), 117- 117, Aug. 2018
|
36 | 上部消化管内視鏡検査を契機に診断にいたったシカゴ分類で分類不能の食道運動障害の1例 , Progress of Digestive Endoscopy, 93( Suppl.), s94- s94, Jun. 2018
|
37 | 治療に難渋した好酸球性胆管炎の1例 , 日本内科学会関東地方会, 642回, 20- 20, Jun. 2018
|
38 | SIGNIFICANT REDUCTION OF MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER (M2BPGI) PROTEIN LEVELS IN PATIENTS WHO ACHIEVED SUSTAINED VIROLOGICAL RESPONSE (SVR) BUT NOT THOSE COULD NOT BY THE COMBINATION THERAPY OF DACLATASVIR/ASUNAPREVIR , GASTROENTEROLOGY, 154( 6), S729- S729, May. 2018
|
39 | DISSECTING THE ROLE OF MACROPHAGE INHIBITORY FACTOR (MIF) ON MURINE NAFLD/NASH MODEL , GASTROENTEROLOGY, 154( 6), S1155- S1155, May. 2018
|
40 | 慢性肝炎および肝硬変患者における握力の検討 , 肝臓, 59( Suppl.1), A397- A397, Apr. 2018
|
41 | 日本人PBC患者の予後予測におけるGlobeスコア・UK-PBCスコアの妥当性の検証 , 肝臓, 59( Suppl.1), A454- A454, Apr. 2018
|
42 | 慢性C型肝炎におけるM2BPGi測定の有用性及びDaclatasvir/Asunaprevir治療後の変化 , 肝臓, 59( Suppl.1), A316- A316, Apr. 2018
|
43 | 患者アンケートを実施してみえた痒みの顕在化 GLSG:Gunma Liver Study Group , 日本消化器病学会雑誌, 115( 臨増総会), A344- A344, Mar. 2018
|
44 | 胃食道逆流症の病態と治療戦略 全身性強皮症患者における胃食道逆流症と肺病変との関連性 , 日本消化管学会雑誌, 2( Suppl.), 94- 94, Feb. 2018
|
45 | Dissecting The role of macrophage migration inhibitory (MIF) in murine NAFLD model , CANCER SCIENCE, 109, 1122- 1122, Jan. 2018
|
46 | Effect of an oral nutrition supplement on prevention of hand-foot syndrome in sorafenib for hepatocellular arcinoma , ANNALS OF ONCOLOGY, 28, , Oct. 2017
|
47 | Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Infected with HCV GT1-3 by Renal Impairment Status: A Pooled Analysis of Two Phase 3 Japanese Trials , HEPATOLOGY, 66, 634A- 635A, Oct. 2017
|
48 | PNI(prognostic nutritional index)は、ソラフェニブ投与中の進行肝細胞癌患者の予後因子である 多施設共同研究 , 肝臓, 58( Suppl.2), A640- A640, Sep. 2017
|
49 | CERTAIN-1/CERTAIN-2試験での日本人C型肝炎患者へのグレカプレビル/ピブレンタスビル療法における耐性変異の解析 , 肝臓, 58( Suppl.2), A595- A595, Sep. 2017
|
50 | マウス脂肪性肝炎モデルにおけるMIF(マクロファージ遊走阻止因子)の役割 , 日本癌学会総会記事, 76回, P- 3304, Sep. 2017
|
51 | 多施設データを用いた進行肝細胞癌に対するSorafenibの治療成績の検討 , 肝臓, 58( Suppl.2), A599- A599, Sep. 2017
|
52 | 当院における非B非C型肝癌の特徴 , 肝臓, 58( Suppl.2), A605- A605, Sep. 2017
|
53 | 30mm超単発肝細胞癌に対するTACEの予後・治療効果予測因子の検討 , 肝臓, 58( Suppl.2), A608- A608, Sep. 2017
|
54 | 多発肝細胞癌に対する動注用シスプラチン・ミリプラチン併用療法の検討 , 肝臓, 58( Suppl.2), A615- A615, Sep. 2017
|
55 | 当院におけるルストロンポバグの使用経験 , 肝臓, 58( Suppl.2), A645- A645, Sep. 2017
|
56 | 当院におけるstage4進行肝細胞癌症例の予後についての検討 , 肝臓, 58( Suppl.1), A340- A340, Apr. 2017
|
57 | 当院におけるHCV感染血友病患者に対する直接作用型抗HCV薬治療に関する検討 , 日本血栓止血学会誌, 28( 2), 224- 224, Apr. 2017
|
58 | 自閉症を有するクローン病2例のトランジションを経験して , 日本小児栄養消化器肝臓学会雑誌, 31( 1), 32- 32, Apr. 2017
|
59 | 1型C型慢性肝炎に対する12週間投与DAA製剤による前向き多施設観察研究(中間成績) , 肝臓, 58( Suppl.1), A305- A305, Apr. 2017
|
60 | C型肝炎に対するレジパスビル/ソホスブビルの実臨床での評価 , 日本消化器病学会雑誌, 114( 臨増総会), A364- A364, Mar. 2017
|
61 | 食道胃接合部形態による逆流性食道炎のリスク評価 , 胃病態機能研究会誌, 49, 35- 35, Feb. 2017
|
62 | 急激な臨床経過を辿った肝血管肉腫の1例 , 日本内科学会関東地方会, 630回, 54- 54, Feb. 2017
|
63 | CERTAIN-1: efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis , JOURNAL OF HEPATOLOGY, 66( 1), S527- S527, 2017
|
64 | Safely and usefulness of capsule endoscopy in children and minors , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, 134- 134, Nov. 2016
|
65 | 1型C型慢性肝炎に対して、ombitasvir/paritaprevir/ritonavir併用療法を投与中に著明な肝障害を認め、減量して継続投与している1例 , 肝臓, 57( Suppl.3), A781- A781, Oct. 2016
|
66 | 1型C型慢性肝炎に対して、22日間の内服でSVR24を得られたdaclatasvir/asunaprevir併用療法の1例 , 肝臓, 57( Suppl.3), A782- A782, Oct. 2016
|
67 | 胆道出血にて発症し、B-TACEで止血し長期生存が得られているHCCの一例 , 肝臓, 57( Suppl.3), A801- A801, Oct. 2016
|
68 | 肝臓 限局性肝がんに対する新たな治療選択肢 1.5mm細径治療針を用いた肝悪性腫瘍に対する経皮的凍結凝固療法の初期報告 , 日本癌治療学会学術集会抄録集, 54回, WS35- 4, Oct. 2016
|
69 | N-butyl-2-cyanoacrylate局注後の持続する菌血症に対してballoon-occluded retrograde transvenous obliteration(BRTO)を施行した胃静脈瘤破裂の1例 , 肝臓, 57( Suppl.3), A822- A822, Oct. 2016
|
70 | 長期にわたるウルソデオキシコール酸及びグリチルリチン静注製剤の投与により、持続的ウイルス学的著効が得られたC型慢性肝炎の1例 , 肝臓, 57( Suppl.3), A780- A780, Oct. 2016
|
71 | 肝細胞癌の多発症例に対するBalloon-occluded transarterial chemoembolization(B-TACE)の有用性の検討 , 肝臓, 57( Suppl.2), A562- A562, Sep. 2016
|
72 | B-TACE(balloon-occluded transcatheter arterial chemoembolization)の治療効果因子と予後因子の検討 , 肝臓, 57( Suppl.2), A561- A561, Sep. 2016
|
73 | Assessment of Esophago-Gastric Junction Morphology and Barrier Function by Combined High Resolution Manometry and Endoscopy for Evaluating a Risk of Gastroesophageal Reflux Disease , GASTROENTEROLOGY, 150( 4), S289- S289, Apr. 2016
|
74 | 門亢症に対するIVRと内視鏡所見の変化 出血をきたしたsevere PHGに対するPSEの有用性について , Progress of Digestive Endoscopy, 88( Suppl.), s104- s104, Dec. 2015
|
75 | Fecal lactoferrin is a useful biomarker for mucosal healing in cases of ulcerative colitis during monocyte adsorptive apheresis therapy , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 308- 308, Dec. 2015
|
76 | Shortening the procedure time of pancreatobiliary endoscopy using a short guidewire in combination with the side lock technique , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 226- 226, Dec. 2015
|
77 | Randomized controlled trial of epirubicin and miriplatin using together with TACE for hepatocellular carcinoma , ANNALS OF ONCOLOGY, 26, 94- 95, Nov. 2015
|
78 | Endoscopic Cascade Stomach Is a Risk Factor for Reflux Esophagitis , AMERICAN JOURNAL OF GASTROENTEROLOGY, 110, S1017- S1018, Oct. 2015
|
79 | Skeletal muscle depletion as a poor prognostic factor in the treatment with sorafenib for male patients with advanced hepatocellular carcinoma: a retrospective study , HEPATOLOGY, 62, 449A- 450A, Oct. 2015
|
80 | 当院における進行肝細胞癌に対するソラフェニブ治療におけるTACE/TAI併用についての検討 , 肝臓, 56( Suppl.2), A746- A746, Sep. 2015
|
81 | Response to Licinio et al. , American Journal of Gastroenterology, 110( 7), 1086- 1087, Jul. 8, 2015
|
82 | OMBITASVIR/PARITAPREVIR/RITONAVIR FOR TREATMENT OF HCV GENOTYPE 1b IN JAPANESE PATIENTS WITH OR WITHOUT CIRRHOSIS: RESULTS FROM GIFT-I , JOURNAL OF HEPATOLOGY, 62, S235- S235, Apr. 2015
|
83 | 1b型高ウイルス量C型慢性肝炎に対するシメプレビル/ペグインターフェロン/リバビリン併用療法の包括化個別化医療に基づいた多施設共同前向き試験 , 肝臓, 56( Suppl.1), A487- A487, Apr. 2015
|
84 | Genotype 1b高ウイルス量のC型慢性肝炎に対するテラプレビル/ペグインターフェロンα2b/リバビリン3剤併用による包括化個別化治療 , 肝臓, 55( Suppl.2), A656- A656, Sep. 2014
|
85 | 当院における肝硬変患者の腹水に対するTolvaptanの使用経験 , 日本消化器病学会雑誌, 111( 臨増大会), A925- A925, Sep. 2014
|
86 | C型肝炎における亜鉛の意義 , 肝臓, 55( Supplement 1), A136- , Apr. 20, 2014
|
87 | Macrophage migration inhibitory factor (MIF) attenuates hepatic steatosis and fibrosis but accelarates liver tumors development in murine NAFLD model , HEPATOLOGY, 58, 530A- 530A, Oct. 2013
|
88 | 群馬県におけるE型肝炎の最近2年間の発生状況 , 日本消化器病学会雑誌, 110, A824- , Sep. 15, 2013
|
89 | Final Results of a Clinical Trial of a 2-Week Lead-in Therapy With Interferon Beta Plus Ribavirin Before Peginterferon alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 1 and High Viral Loads , GASTROENTEROLOGY, 144( 5), S984- S984, May. 2013
|
90 | Amelioration of Hepatic Steatosis in Obese Mice by Mk-0626, a Selective alpha-Amino Amide Dipeptidyl Peptidase-4 Inhibitor , GASTROENTEROLOGY, 144( 5), S1018- S1018, May. 2013
|
91 | Macrophage Migration Inhibitory Factor (MIF) Attenuates Liver Inflammation, Steatosis, and Fibrosis in Murine Non-Alcoholic Liver Disease Model , GASTROENTEROLOGY, 142( 5), S921- S921, May. 2012
|
92 | A 2-Week Lead-in Therapy With Interferon Beta Plus Ribavirin Before Peginterferon alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 1 and High Viral Loads , GASTROENTEROLOGY, 142( 5), S959- S959, May. 2012
|
93 | The Role of Macrophage Migration Inhibitory Factor (MIF) in Acute and Chronic Carbon Tetrachloride Induced Liver Injury: MIF Inhibits Chronic CCl4-Induced Liver Fibrosis , GASTROENTEROLOGY, 142( 5), S973- S973, May. 2012
|
94 | 群馬県における肝疾患診療ネットワークの現状と取り組み , 肝臓, 53( Supplement 1), A351- , Apr. 30, 2012
|
95 | NASH基礎 MIF(マクロファージ遊走阻止因子)は高脂肪食による肝障害、脂質沈着(Steatosis)、および肝線維化を抑制する , 肝臓, 53( Suppl.1), A302- A302, Apr. 2012
|
96 | 急性/慢性四塩化炭素肝炎モデルにおけるMIF(マクロファージ遊走阻止因子)の役割 MIFは肝線維化を抑制する , 肝臓, 53( Suppl.1), A509- A509, Apr. 2012
|
97 | 群馬県における肝炎医療費助成の現状と地域性 , 日本内科学会雑誌, 101, 154- , Feb. 20, 2012
|
98 | PEG‐IFNα2b投与における血中亜鉛濃度の変動と効果に関する検討 , 肝臓, 52( Supplement 2), A601- , Sep. 10, 2011
|
99 | Constitutive Active/Androstane Receptor Promotes Hepatocarcinogenesis in a Mouse Model of Non-Alcoholic Steatohepatitis , GASTROENTEROLOGY, 140( 5), S909- S909, May. 2011
|
100 | Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road , GASTROENTEROLOGY, 140( 5), S911- S911, May. 2011
|
101 | TGF-alpha Attenuates Hepatic Fibrosis: Possible Involvement of Matrix Metalloproteinase-1 , GASTROENTEROLOGY, 140( 5), S979- S979, May. 2011
|
102 | 急性B型肝炎の感染の実態からみたuniversal vaccination(UV)の必要性 , 肝臓, 52( Supplement 1), A302- , Apr. 25, 2011
|
103 | 群馬県におけるWilson病症例の検討―小児期と青年期発症例の比較― , 日本内科学会雑誌, 100, 121- , Feb. 20, 2011
|
104 | HGF PROMOTES DEN-INDUCED HEPATOCARCINOGENESIS, BUT ATTENUATES MCD-INDUCED LIVER INFLAMMATION AND FIBROSIS , HEPATOLOGY, 52( 4), 935A- 935A, Oct. 2010
|
105 | B型慢性肝疾患に対するEntecavir単独療法及びAdefovir dipivoxilとの併用療法の長期予後 , 肝臓, 51( Suppl.1), A144- A144, Apr. 2010
|
106 | B型肝硬変に対するB型キャリアーからの生体肝移植 その後の経過 , The Kitakanto Medical Journal, 59( 3), 307- 308, Aug. 2009
|
107 | Response-Guided Therapy of Peginterferon Alpha 2B Plus Ribavirin for Chronic Hepatitis C with Genotype 2 and a High Viral Road As An Effective Method Optimizing Therapy Duration , GASTROENTEROLOGY, 136( 5), A485- A486, May. 2009
|
108 | Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis , GASTROENTEROLOGY, 136( 5), A847- A847, May. 2009
|
109 | Randomized Controlled Study of Endoscopic Sphincterotomy with the Endocut Mode or Conventional Blended Cut Mode , GASTROINTESTINAL ENDOSCOPY, 69( 5), AB155- AB155, Apr. 2009
|
110 | 群馬県におけるE型肝炎 , 肝臓, 49( Supplement 3), A732- , Oct. 30, 2008
|
111 | 薬物性肝障害重症型の推移 , 肝臓, 49( Suppl.1), A124- A124, Apr. 2008
|
112 | Stevioside as a possible antiviral agent for hepatitis C virus infection , GASTROENTEROLOGY, 134( 4), A789- A789, Apr. 2008
|
113 | Health related quality of life in patients with primary biliary cirrhosis using a Japanese version of the PBC-40 questionnaire , GASTROENTEROLOGY, 134( 4), A268- A268, Apr. 2008
|
114 | B型慢性肝疾患に対するEntecavir単独療法及びAdefovir dipivoxilとの併用療法の有用性 , 肝臓, 49( Suppl.1), A337- A337, Apr. 2008
|
115 | Hypoxemia with high alveolar-arterial oxygen gradient but no lung involvement in a patient with Churg-Strauss syndrome: case report. , Int J Immunopathol Pharmacol, 21( 1), 251- 3, 2008
|
116 | Lamivudine投与例を含むB型急性肝炎自験例の検討 , 肝臓, 48( Suppl.2), A404- A404, Sep. 2007
|
117 | Predictive factors of sustained virological response to peginterferon alpha-2a therapy in the patients with chronic hepatitis C despite the discontinuation of peginterferon alpha-2a therapy due to adverse events , GASTROENTEROLOGY, 132( 4), A642- A642, Apr. 2007
|
118 | Incidence and risk factors for hepatic and extrahepatic malignancies in primary biliary cirrhosis in Japan , GASTROENTEROLOGY, 132( 4), A198- A198, Apr. 2007
|
119 | 生体肝移植後のC型肝炎再発に対する治療 , 移植, 41( 5), 489- 489, Oct. 2006
|
120 | Computed tomography (CT)-guided trans-pulmonary radiofrequency ablation for hepatocellular carcinoma located in the hepatic dome , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A168- A168, Mar. 2006
|
121 | Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity , JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A208- A208, Mar. 2006
|
122 | C型慢性肝炎低ウイルス量症例の宿主側因子の検討 , 日本消化器病学会雑誌, 103( 臨増総会), A274- A274, Mar. 2006
|
123 | A randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2 , AMERICAN JOURNAL OF GASTROENTEROLOGY, 100( 9), S111- S112, Sep. 2005
|
124 | Hepatocellular carcinoma in the extremely elderly patients: Clinical characteristics, prognosis and patient survival analysis. , GASTROENTEROLOGY, 128( 4), A452- A452, Apr. 2005
|
125 | Activation of PPAR Gamma inhibits cell growth and induces apoptosis in human liver cancer cells. , GASTROENTEROLOGY, 118( 4), A921- A921, Apr. 2000
|
Conference Activities & Talks |
No. | Title, Conference, Publication date, Promoter, Venue
|
1 | 分子標的薬と免疫チェックポイント阻害薬による肝障害(症例報告も可) 当院における免疫チェックポイント阻害薬による肝障害の検討, 肝臓, Apr. 2019, ,
|
2 | ダクラタスビル・アスナプレビル併用療法不成功例におけるDAAs再治療例の検討, 肝臓, Apr. 2019, ,
|
3 | ペムブロリズマブによる急性肝不全非昏睡型の一例, 肝臓, Apr. 2019, ,
|
4 | C型慢性肝炎難治例に対するDAA再治療の検討, 日本消化器病学会雑誌, Mar. 2019, ,
|
5 | 当院における肝臓病教室・患者サロンの現状, 日本消化器病学会雑誌, Mar. 2019, ,
|
6 | 高度黄疸を来した多中心性キャッスルマン病の1例, 日本消化器病学会関東支部例会プログラム・抄録集, Feb. 2019, ,
|
7 | 局所製剤未使用にも関わらず再燃時に直腸に炎症を認めなかった潰瘍性大腸炎の1例, Progress of Digestive Endoscopy, Dec. 2018, ,
|
8 | 多様なC型慢性肝炎special populationに対するglecaprevir/pibrentasvir療法の巧みな実臨床応用, 肝臓, Nov. 2018, ,
|
9 | C型慢性肝炎DAA再治療例の検討, 肝臓, Nov. 2018, ,
|
10 | 指状嵌入樹状細胞肉腫浸潤による急性肝不全の一例, 肝臓, Nov. 2018, ,
|
11 | DAA治療不成功例に対するDAAによるサルベージ治療戦略, 肝臓, Nov. 2018, ,
|
12 | NAFLD/NASHモデルにおけるマクロファージ遊走阻止因子(MIF)の役割, 日本消化器病学会雑誌, Oct. 2018, ,
|
13 | 肝細胞癌に対するダブルプラチナ療法の効果予測因子についての検討, 肝臓, Sep. 2018, ,
|
14 | 門脈-大循環分流術において上腸間膜静脈のバルーン閉塞による血流コントロールが有効であった一例, 日本門脈圧亢進症学会雑誌, Aug. 2018, ,
|
15 | 上部消化管内視鏡検査を契機に診断にいたったシカゴ分類で分類不能の食道運動障害の1例, Progress of Digestive Endoscopy, Jun. 2018, ,
|
16 | 治療に難渋した好酸球性胆管炎の1例, 日本内科学会関東地方会, Jun. 2018, ,
|
17 | 患者アンケートを実施してみえた痒みの顕在化 GLSG:Gunma Liver Study Group, 日本消化器病学会雑誌, Mar. 2018, ,
|
18 | 胃食道逆流症の病態と治療戦略 全身性強皮症患者における胃食道逆流症と肺病変との関連性, 日本消化管学会雑誌, Feb. 2018, ,
|
19 | マウス脂肪性肝炎モデルにおけるMIF(マクロファージ遊走阻止因子)の役割, 日本癌学会総会記事, Sep. 2017, ,
|
20 | SVR100%を目指すDAAs治療 DAA未治療日本人C型慢性肝炎患者へのグレカプレビルとピブレンタスビル(G/P)による8週治療レジメンにおける有効性と安全性, 肝臓, Sep. 2017, ,
|
21 | SVR100%を目指すDAAs治療 DAA未治療日本人C型慢性肝炎患者へのグレカプレビルとピブレンタスビル(G/P)による8週治療レジメンにおける有効性と安全性, 日本消化器病学会雑誌, Sep. 2017, ,
|
22 | 1型C型慢性肝炎に対する12週間投与DAA製剤による前向き多施設観察研究(中間成績), 肝臓, Apr. 2017, ,
|
23 | 自閉症を有するクローン病2例のトランジションを経験して, 日本小児栄養消化器肝臓学会雑誌, Apr. 2017, ,
|
24 | 当院におけるHCV感染血友病患者に対する直接作用型抗HCV薬治療に関する検討, 日本血栓止血学会誌, Apr. 2017, ,
|
25 | 急激な臨床経過を辿った肝血管肉腫の1例, 日本内科学会関東地方会, Feb. 2017, ,
|
26 | 食道胃接合部形態による逆流性食道炎のリスク評価, 胃病態機能研究会誌, Feb. 2017, ,
|
27 | 1型C型慢性肝炎に対して、22日間の内服でSVR24を得られたdaclatasvir/asunaprevir併用療法の1例, 肝臓, Oct. 2016, ,
|
28 | 1型C型慢性肝炎に対して、ombitasvir/paritaprevir/ritonavir併用療法を投与中に著明な肝障害を認め、減量して継続投与している1例, 肝臓, Oct. 2016, ,
|
29 | 長期にわたるウルソデオキシコール酸及びグリチルリチン静注製剤の投与により、持続的ウイルス学的著効が得られたC型慢性肝炎の1例, 肝臓, Oct. 2016, ,
|
30 | C型慢性肝炎合併透析患者に対するombitasvir/paritaprevir/ritonavir治療, 肝臓, Oct. 2016, ,
|
31 | Ipilimumabによる薬物性肝障害の多様性, 肝臓, Oct. 2016, ,
|
32 | B型肝炎合併C型慢性肝炎に対するDAA治療におけるB型肝炎ウイルスの再活性化の2例, 肝臓, Oct. 2016, ,
|
33 | C型肝炎の残された問題点 遺伝子1b型C型慢性肝炎合併透析患者に対するダクラタスビル/アスナプレビル併用療法(症例報告), 肝臓, Oct. 2016, ,
|
34 | 肝臓 限局性肝がんに対する新たな治療選択肢 1.5mm細径治療針を用いた肝悪性腫瘍に対する経皮的凍結凝固療法の初期報告, 日本癌治療学会学術集会抄録集, Oct. 2016, ,
|
35 | ダクラタスビル/アスナプレビル併用療法にて浮腫、腹水、腎機能の改善を得られたGenotype 1型HCV関連腎症の1例, 肝臓, Oct. 2016, ,
|
36 | 遺伝子2型C型慢性肝炎患者に対するソホスブビル+リバビリン併用療法(中間成績), 肝臓, Sep. 2016, ,
|
37 | PPARγの新規転写共役因子HELZ2の非アルコール性脂肪性肝疾患における役割, 肥満研究, Sep. 2016, ,
|
38 | 診断に苦慮したサイトメガロウィルス腸炎の1例, 日本内科学会関東地方会, Jun. 2016, ,
|
39 | PPARγの新たな転写共役因子HELZ2の肥満症における役割, 糖尿病, Apr. 2016, ,
|
40 | 脂肪組織 アディポサイエンスの展開 PPARγの新たな転写共役因子HELZ2の肥満症における役割, 日本内分泌学会雑誌, Apr. 2016, ,
|
41 | 尿酸値上昇はソホスブビル+リバビリン併用療法の注意すべき有害事象である, 肝臓, Apr. 2016, ,
|
42 | 坐位での食道内圧検査を加味したEGJ outflow obstructionの病態, 胃病態機能研究会誌, Feb. 2016, ,
|
43 | 内視鏡的膵管ステント留置により化学療法継続が可能となった転移誘発性膵炎の2症例, 日本内科学会関東地方会, Feb. 2016, ,
|
44 | GIFT-I: ALT Changes with Ombitasvir/Paritaprevir/Ritonavir and Concomitant use of Hepatoprotectives, , 2016, ,
|
45 | GIFT-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir in Elderly Japanese Patients, , 2016, ,
|
46 | GIFT-I: Durability of response of ombitasvir/paritaprevir/ritonavir in HCV GT1b Japanese patients, , 2016, ,
|
47 | GIFT-I: Ombitasvir/Paritaprevir/Ritonavir Safety and Efficacy in Renally-Impaired Japanese Patients, , 2016, ,
|
48 | Therapy with Daclatasvir and Asunaprevir for Dialysis Patients with Hepatitis C: Case Reports, , 2016, ,
|
49 | アダリムマブが有効であった消化器病変を伴う不全型ベーチェット病の1例, Progress of Digestive Endoscopy, Dec. 2015, ,
|
50 | 輸血によるE型急性肝炎の1例, 日本内科学会関東地方会, Oct. 2015, ,
|
51 | 当院における進行肝細胞癌に対するソラフェニブ治療におけるTACE/TAI併用についての検討, 肝臓, Sep. 2015, ,
|
52 | トラニラストによる膀胱炎様症状を伴った薬物性肝障害の臨床的検討, 肝臓, Sep. 2015, ,
|
53 | 1b型高ウイルス量C型慢性肝炎に対するシメプレビル/ペグインターフェロン/リバビリン併用療法の包括化個別化医療に基づいた多施設共同前向き試験, 肝臓, Apr. 2015, ,
|
54 | EFFECT OF Β-HYDROXY-Β-METHYLBUTYRIC ACID, L-GLUTAMINE, AND L-ARGININE ON PREVENTION OF HAND-FOOT SYNDROME IN SORAFENIB TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA: A NON-RANDOMIZED CLINICAL TRIAL, , 2015, ,
|
55 | Malignant peripheral nerve sheath tumor of the liver., , 2015, ,
|
56 | Incidence of sarcopenia among patients in an acute-phase hospital., , 2015, ,
|
57 | OMBITASVIR/PARITAPREVIR/RITONAVIR FOR TREATMENT OF HCV GENOTYPE 1B IN JAPANESE PATIENTS WITH OR WITHOUT CIRRHOSIS: RESULTS FROM GIFT-I, , 2015, ,
|
58 | CORRELATION BETWEEN NUTRITIONAL ASSESSMENT WITH THE INDIRECT CALORIMETER AND HOSPITALIZATION DURATION: A CROSS-SECTIONAL STUDY., , 2015, ,
|
59 | Characteristics of skeletal muscle mass of patinets in an acute care hospital: A crosssectional study, , 2015, ,
|
60 | A case of chronic hepatitis C accompanied by marked thrombocytopenia during combination therapy with daclatasvir and asunaprevir, , 2015, ,
|
61 | Endoscopic Cascade Stomach Is a Risk Factor for Reflux Esophagitis, , 2015, ,
|
62 | Skeletal muscle depletion as a poor prognostic factor in the treatment with sorafenib for male patients with advanced hepatocellular carcinoma: a retrospective study, , 2015, ,
|
63 | Long-term efficacy and safety of the interferon- and ribavirin-free regimen of ABT-450r and omitasvir in HCV genotype 1b-infected treatment-experienced Japanese patients, , 2015, ,
|
64 | MK-0626, a selective DPP-4 inhibitor, ameliorates hepatic steatosis in ob/ob mice., , 2015, ,
|
65 | GIFT-I: Efficacy and Safety of Open-Label Ombitasvir/Paritaprevir/Ritonavir in HCV Genotype 1b-infected Japanese Adults, , 2015, ,
|
66 | GIFT-I: Changes in Key Liver Biomarkers in Cirrhotic HCV Genotype 1b-infected Patients Receiving 12 Weeks of Ombitasvir/Paritaprevir/r, , 2015, ,
|
67 | Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy, , 2015, ,
|
68 | A case of endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation., , 2015, ,
|
69 | Shortening the procedure time of pancreato-biliary endoscopy using a short guide-wire in combination with the side lock technique., , 2015, ,
|
70 | Fecal lactoferrin is a useful biomarker for mucosal healing in cases of ulcerative colitis during monocyte adsorptive apheresis therapy., , 2015, ,
|
71 | Hepatic angiosarcoma with dyskeratosis congenital., , 2015, ,
|
72 | 「MK-0626, a selective DPP-4 inhibitor, ameliorates hepatic steatosis in ob/ob mice. 」, , 2015, ,
|
73 | 肝表および横隔膜下の肝細胞癌に対し経皮的凍結療法を施行した1例, Personalized Medicine Universe. Japanese Edition, Nov. 2014, ,
|
74 | 抗インターフェロンα抗体の出現した2型高ウイルス量C型慢性肝炎難治例に対して、48週間のβインターフェロン及びリバビリン併用療法が奏功した1例, 肝臓, Oct. 2014, ,
|
75 | 難治性2型C型慢性肝炎に対する72週ペグインターフェロンalpha 2a+リバビリン併用療法, 肝臓, Oct. 2014, ,
|
76 | モサプリドによる劇症肝炎(亜急性型)の1救命例およびモサプリドによる肝障害の当院における現状, 肝臓, Oct. 2014, ,
|
77 | Glycogenic Hepatopathy, 肝臓, Oct. 2014, ,
|
78 | Sorafenibによる重篤な肝障害をきたすも、ステロイド投与により対処可能であった薬物性肝障害の1例, 肝臓, Oct. 2014, ,
|
79 | 群馬県におけるC型肝炎患者の就労支援の取り組み 平日夜間、土日にインターフェロン治療可能な施設の把握と病診連携の推進, 肝臓, Oct. 2014, ,
|
80 | ダナパロイドナトリウムが有用であった脾動脈瘤破裂後の門脈血栓症の1救命例, 肝臓, Oct. 2014, ,
|
81 | 肝細胞増殖因子(HGF)は、オートクリン機構によるc-metの活性化によりDEN投与による肺腫瘍形成を促進する(HGF promotes lung tumorigenesis via autocrine c-met activation in transgenic mice treated with diethylnitrosamine), 日本癌学会総会記事, Sep. 2014, ,
|
82 | 当院におけるEUS導入後の膵内分泌腫瘍診断についての検討, 日本消化器病学会雑誌, Sep. 2014, ,
|
83 | Genotype 1b高ウイルス量のC型慢性肝炎に対するテラプレビル/ペグインターフェロンα2b/リバビリン3剤併用による包括化個別化治療, 肝臓, Sep. 2014, ,
|
84 | Isaacs症候群に合併した食道静脈瘤に対する内視鏡治療の1例, Gastroenterological Endoscopy, Apr. 2014, ,
|
85 | C型肝炎に対するDAAを用いた治療戦略 C型慢性肝炎(Genotype 2難治例)に対するTelaprevir/PEG-IFNα-2b/RBV 3剤併用療法の国内第III相臨床試験成績, 肝臓, Apr. 2014, ,
|
86 | 当院におけるC型慢性肝炎(Genotype 2難治例)に対するTelaprevir/PEG-IFNα-2b/RBV3剤併用療法の治験成績, 肝臓, Apr. 2014, ,
|
87 | Comparison of Clinical Characteristics and Survival between Patients with HCC from NASH and Those from Non-B, Non-C and Non-NASH after Curative Resection for HCC., , 2014, ,
|
88 | The long-term prognosis of adefovir dipivoxil monotherapy for Japanese patients with lamivudine-resistant chronic hepatitis B., , 2014, ,
|
89 | A Prospective Multicenter Clinical Trial of a 2-week Antecedent Therapy with Interferon Beta Plus Ribavirin Prior to Peginterferon Alpha-2b Plus Ribavirin for Chronic Hepatitis C with Genotype 1 and High Viral Loads, , 2014, ,
|
90 | Comparison of young and old patients with chronic hepatitis C treated by triple therapy with peginterferon, telaprevir and ribavirin., , 2014, ,
|
91 | Improvement of antiviral treatment for hepatitis C in Takasaki, Japan., , 2014, ,
|
92 | Pilot study of granulocytapheresis and leukocytapheresis for the treatment of severe alcoholic hepatitis., , 2014, ,
|
93 | Clinical Features of acute hepatitis E recently found in Gunma prefecture, Japan., , 2014, ,
|
94 | Early prediction of response to transarterial chemotherapy using CDDP powder in patients with unresectable hepatocellular carcinoma., , 2014, ,
|
95 | Interferon- and Ribavirin-Free Regimen of ABT-450/r and ABT-267 in Treatment-Experienced Japanese Patients Infected With HCV Genotype 1b or Genotype 2, , 2014, ,
|
96 | Isaacs症候群に合併したアルコール性肝硬変の1例, 日本内科学会関東地方会, Dec. 2013, ,
|
97 | 炎症性腸疾患に対し免疫調節薬を使用している患者のB型肝炎ウイルス感染の実態調査, 日本消化器病学会雑誌, Sep. 2013, ,
|
98 | 自己免疫性膵炎におけるIgG4関連疾患診断の意義, 日本消化器病学会雑誌, Sep. 2013, ,
|
99 | 群馬県におけるE型肝炎の最近2年間の発生状況, 日本消化器病学会雑誌, Sep. 2013, ,
|
100 | Nonalcoholic steatohepatitis(NASH)に合併した肝細胞癌(HCC)根治術後の予後(非B非C非NASH-HCCとの比較), 肝臓, Sep. 2013, ,
|
101 | 年齢およびBMIが一致した集団を用いた非アルコール性脂肪性肝炎の女性患者における長期転帰の前向き研究(A Prospective Study of Long-term Out-comes in Female Patients with Nonalcoholic Steatohepatitis Using Age- and Body Mass Index-matched Cohorts), 肝臓, Sep. 2013, ,
|
102 | 急性/慢性四塩化炭素肝炎モデルにおけるMIF(マクロファージ遊走阻止因子)の役割 MIFは肝線維化を抑制する, 日本臨床分子医学会学術総会プログラム・抄録集, Apr. 2013, ,
|
103 | 1b型高ウイルス量C型慢性肝炎に対するIFNβ分割/Ribavirin先行投与後Peg-IFNα-2b/Ribavirin療法, 肝臓, Apr. 2013, ,
|
104 | ヒト胆管細胞癌株におけるgefitinib・gemcitabine併用療法の有用性に関する検討, 肝臓, Apr. 2013, ,
|
105 | The First Acute Hepatitis E Viral Infection with a Spanish TypeGenotype 3f Strain in Japan., , 2013, ,
|
106 | Final results of a clinical trial of a 2-week lead-in therapy with interferon beta plus ribavirin before peginterferon alpha-2b plus ribavirin for chronic hepatitis C with genotype 1 and high viral loads., , 2013, ,
|
107 | Werner Syndrome and NASH., , 2013, ,
|
108 | Amelioration of hepatic steatosis in obese mice by MK-0626, a selective α-amino amide dipeptidyl peptidase-4 inhibitor., , 2013, ,
|
109 | Transarterial Chemothrapy using CDDP Powder in Patients withUnresectable Hepatocellular Carcinoma., , 2013, ,
|
110 | C型慢性肝炎genotype2型症例でのレスポンスガイド療法とIL28B遺伝子多型測定の意義, 臨床薬理, Oct. 2012, ,
|
111 | 1型糖尿病フォロー中に著明な肝腫大と肝機能障害を契機に診断されたGlycogenic hepatopathyの2症例, 肝臓, Oct. 2012, ,
|
112 | 自然破裂・消退した巨大肝嚢胞の一例, 肝臓, Oct. 2012, ,
|
113 | 急性肝不全 新たな定義とこれに準拠した診療の展望 当院における急性肝不全症例の臨床的検討, 日本消化器病学会雑誌, Sep. 2012, ,
|
114 | NASH線維化進行群とBMI、年齢、性別をマッチさせたC型肝炎線維化進行群/NASH線維化軽度群の予後(全生存率・肝関連疾患/心血管イベント発生率)の前向き比較試験, 肝臓, Sep. 2012, ,
|
115 | 免疫抑制・化学療法により発症するB型肝炎対策ガイドラインの検証と発展へのアプローチ, 肝臓, Sep. 2012, ,
|
116 | 小腸内視鏡の現況と展望 当科及び関連施設による小腸内視鏡診断・治療の現況, Progress of Digestive Endoscopy, Jun. 2012, ,
|
117 | 肝癌根治的治療後のinterferon(IFN)療法における予後改善効果に関する検討, 肝臓, Apr. 2012, ,
|
118 | 急性/慢性四塩化炭素肝炎モデルにおけるMIF(マクロファージ遊走阻止因子)の役割 MIFは肝線維化を抑制する, 肝臓, Apr. 2012, ,
|
119 | 肝炎診療 群馬県における肝疾患診療ネットワークの現状と取り組み, 肝臓, Apr. 2012, ,
|
120 | NASH基礎 MIF(マクロファージ遊走阻止因子)は高脂肪食による肝障害、脂質沈着(Steatosis)、および肝線維化を抑制する, 肝臓, Apr. 2012, ,
|
121 | 臓器線維化(肝・膵を中心)研究・診療の最前線 抗酸化作用を有するCa拮抗薬アゼルニジピンの肝線維化抑制効果とそのメカニズム 臨床応用の可能性, 日本消化器病学会雑誌, Mar. 2012, ,
|
122 | アルゴンプラズマ凝固療法(APC)を繰り返すことで出血コントロールが可能であった難治性放射線性胃炎3症例の比較, 日本消化器病学会雑誌, Mar. 2012, ,
|
123 | Werner症候群とNASH, 日本内科学会雑誌, Feb. 2012, ,
|
124 | 群馬県における肝炎医療費助成の現状と地域性, 日本内科学会雑誌, Feb. 2012, ,
|
125 | C型慢性肝炎を合併した透析患者へのIFN治療, 日本内科学会雑誌, Feb. 2012, ,
|
126 | The Role of Macrophage Migration Inhibitory Factor (MIF) in Acute and Chronic Carbon Tetrachloride Induced Liver Injury: MIF Inhibits Chronic CCl4-Induced Liver Fibrosis., , 2012, ,
|
127 | Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis., , 2012, ,
|
128 | A 2-Week Lead-in Therapy With Interferon Beta Plus Ribavirin Before Peginterferon alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 1 and High Viral Loads., , 2012, ,
|
129 | Macrophage Migration Inhibitory Factor (MIF) Attenuates Liver Inflammation, Steatosis, and Fibrosis in Murine Non-Alcoholic Liver Disease Model., , 2012, ,
|
130 | Pancreatic stellate cell activation by transforming growth factor-α: possible involvement of matrix metalloproteinase-1 upregulation., , 2012, ,
|
131 | Hepatitis B virus and hepatitis C virus dual infection., , 2012, ,
|
132 | Ligand Dependent Hepatic Gene Expression Profiles of NuclearReceptors Car and PXR., , 2012, ,
|
133 | 肝細胞癌に対するSorafenib投与例の有害事象の検討, 肝臓, Sep. 2011, ,
|
134 | 群馬県における非B非C肝硬変の実態, 肝臓, Sep. 2011, ,
|
135 | C型肝炎治療の新たな展開 Genotype 2かつ高ウイルス量C型慢性肝炎に対するResponse-guided therapy, 肝臓, Sep. 2011, ,
|
136 | 膵の再生と線維化 progenitor cell・stellate cellの役割 TGF-αによる膵星細胞のMMP-1活性増加は遊走能活性化に関与する, 日本消化器病学会雑誌, Sep. 2011, ,
|
137 | 1b型高ウイルス量C型慢性肝炎に対するIFNβ分割/Ribavirin先行投与後、Peg-IFNα-2b plus/Ribavirin療法の前向き試験, 肝臓, Sep. 2011, ,
|
138 | C型肝硬変合併透析患者の膵臓癌への陽子線治療後に発症した難治性胃潰瘍・胃毛細血管拡張症からの出血に対してアルゴンプラズマ凝固療法(APC)が奏功した一例, The Kitakanto Medical Journal, May. 2011, ,
|
139 | Myeloid細胞特異的STAT3ノックアウトマウスでは、四塩化炭素肝炎モデルにおいて肝炎症細胞浸潤と肝障害が解離する, 肝臓, Apr. 2011, ,
|
140 | アルコール性脂肪性肝炎における細胞特異的なSTAT3の役割, 日本消化器病学会雑誌, Mar. 2011, ,
|
141 | 群馬県におけるWilson病症例の検討 小児期と青年期発症例の比較, 日本内科学会雑誌, Feb. 2011, ,
|
142 | 乳癌術後13年目に発症した食道気管瘻の1例, The Kitakanto Medical Journal, Feb. 2011, ,
|
143 | 群馬県におけるE型肝炎ウイルスの発生状況, 日本内科学会雑誌, Feb. 2011, ,
|
144 | HBV reactivationの現況と対策, 日本内科学会雑誌, Feb. 2011, ,
|
145 | Randomized Controlled Study of Endoscopic Sphincterotomy with the Endocut Mode or Conventional Blended Cut Mode., , 2011, ,
|
146 | TGF-alpha Attenuates Hepatic Fibrosis: Possible Involvement of Matrix Metalloproteinase-1., , 2011, ,
|
147 | Constitutive Active/Androstane Receptor Promotes Hepatocarcinogenesis in a Mouse Model of Non-Alcoholic Steatohepatitis., , 2011, ,
|
148 | Response-Guided Therapy as an Effective Strategy on Peginterferon Alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 2 and a High Viral Road., , 2011, ,
|
149 | C型慢性肝炎に対するポリエンホスファチジルコリン(EPL)併用PEG-IFN alfa-2b/ribavirin療法の前向き無作為化比較試験, 肝臓, Sep. 2010, ,
|
150 | Clostridium difficileとMRSAの感染を合併した重症潰瘍性大腸炎の1例, The Kitakanto Medical Journal, Aug. 2010, ,
|
151 | 溶血性貧血を合併したアルコール性肝硬変の一例, The Kitakanto Medical Journal, Aug. 2010, ,
|
152 | 先天性角化異常症(Cole-Engman症候群)に合併した肝原発類上皮性血管内皮腫の一例, The Kitakanto Medical Journal, Aug. 2010, ,
|
153 | 治療前よりEGFR-TKI治療耐性遺伝子変異を有し、急速な経過で死亡した若年性肺腺癌の1例, 日本内科学会関東地方会, Jul. 2010, ,
|
154 | ARDS合併新型インフルエンザA(H1N1)重症肺炎の1例, 日本内科学会関東地方会, Jun. 2010, ,
|
155 | 術後13年目に食道気管瘻で発症した、転移性食道乳癌腫瘍の1例, Progress of Digestive Endoscopy, Jun. 2010, ,
|
156 | 敗血症により肝梗塞を来したと考えられた1剖検例, 日本内科学会関東地方会, May. 2010, ,
|
157 | Genotype 1型高ウイルス量のC型慢性肝炎における薬剤adherenceの確保を目指したPEG-IFNα2a/Ribavirin併用療法, 肝臓, Apr. 2010, ,
|
158 | 四塩化炭素肝炎モデルにおけるMyeloid細胞特異的STAT3の役割, 肝臓, Apr. 2010, ,
|
159 | B型慢性肝疾患に対するEntecavir単独療法及びAdefovir dipivoxilとの併用療法の長期予後, 肝臓, Apr. 2010, ,
|
160 | NASH/NAFLDの病因・病態と予後 NASHの肝線維化進行度別予後とNASH-HCC症例の予後, 肝臓, Apr. 2010, ,
|
161 | 低Na血症に伴う多様な精神神経症状を呈しSIADHを合併した下垂体腫瘍の1例, 日本内科学会関東地方会, Mar. 2010, ,
|
162 | 放射線後逐次化学療法が奏効した血液透析合併肺LCNECの1例, 日本内科学会関東地方会, Feb. 2010, ,
|
163 | Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcholic steatohepatitis., , 2010, ,
|
164 | Clinical Features of Acute Liver Failure in Gunma University Hospital., , 2010, ,
|
165 | Clinical characteristics of null responders to Peg-IFN alpha 2b/Ribavirin therapy for chronic hepatitis C., , 2010, ,
|
166 | HGF promotes DEN-induced hepatocarcinogenesis, but attenuates MCD-induced liver inflammation and fibrosis., , 2010, ,
|
167 | Clostridium difficileとMRSAの感染を合併した重症潰瘍性大腸炎の1例, 日本内科学会関東地方会, Dec. 2009, ,
|
168 | 溶血性貧血を合併したアルコール性肝硬変の1例, 日本内科学会関東地方会, Oct. 2009, ,
|
169 | 肝炎ウイルス治療ガイドラインの検証 ガイドラインを変えるGenotype 2かつ高ウイルス量C型慢性肝炎に対するResponse-guided therapy, 肝臓, Sep. 2009, ,
|
170 | 乳癌術後13年目に発症した食道転移による食道狭窄、食道気管瘻の1例, 日本内科学会関東地方会, Sep. 2009, ,
|
171 | ガイドラインを変えるGenotype2かつ高ウイルス量C型慢性肝炎に対するResponse-guided therapy, 日本消化器病学会雑誌, Sep. 2009, ,
|
172 | 当科における肝細胞癌切除後早期再発例の検討, 日本消化器病学会雑誌, Sep. 2009, ,
|
173 | NASHは生命予後に影響するか? NASH線維化進行度別予後の前向き調査(C型肝炎との比較を含めて), 肝臓, Sep. 2009, ,
|
174 | Endocut modeを用いた内視鏡的乳頭括約筋切開術(EST)における偶発症についての検討, Gastroenterological Endoscopy, Sep. 2009, ,
|
175 | Epo非依存性赤芽球コロニー中に少数のJAK2-V617F陽性クローンを認めたBudd-Chiari症候群の1例, 臨床血液, Sep. 2009, ,
|
176 | 四塩化炭素肝炎モデルにおける肝細胞特異的STAT3の役割, 肝臓, Sep. 2009, ,
|
177 | 化学療法や免疫抑制療法に伴うB型肝炎のreactivationの現況, 肝臓, Sep. 2009, ,
|
178 | B型肝硬変に対するB型キャリアーからの生体肝移植 その後の経過, The Kitakanto Medical Journal, Aug. 2009, ,
|
179 | ダナパロイドナトリウムが著効した門脈血栓症の1例, The Kitakanto Medical Journal, Aug. 2009, ,
|
180 | Steroidの中止による潰瘍性大腸炎合併B型慢性肝炎reactivationの1例, 日本内科学会関東地方会, Jul. 2009, ,
|
181 | 当科における肝細胞癌切除後早期再発例の検討, The Kitakanto Medical Journal, May. 2009, ,
|
182 | 当科におけるRVSを用いたラジオ波焼灼療法の有用性の検討, The Kitakanto Medical Journal, May. 2009, ,
|
183 | 慢性リンパ性白血病薬フルダラビンによりreactivationを起こしたB型肝炎の1例, 日本内科学会関東地方会, Mar. 2009, ,
|
184 | 腫瘍性造血を呈する顆粒球中に少数のJAK2V617F変異クローンが確認されたBudd-Chiari症候群の1例, 日本内科学会雑誌, Feb. 2009, ,
|
185 | Risk factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis., , 2009, ,
|
186 | Response-Guided Therapy of Peginterferon Alpha 2B Plus Ribavirinfor Chronic Hepatitis C with Genotype 2 and a High Viral Road As An Effective Method Optimizing Therapy Duration., , 2009, ,
|
187 | Randomized Controlled Study of Endoscopic Sphincterotomy with the Endocut Mode or Conventional Blended Cut Mode., , 2009, ,
|
188 | 消化管静脈瘤の診断治療戦略 異所性静脈瘤の検討, Progress of Digestive Endoscopy, Dec. 2008, ,
|
189 | 群馬県におけるE型肝炎, 肝臓, Oct. 2008, ,
|
190 | 性差からみたNonalcoholic steatohepatitisの臨床病理学的検討, 日本消化器病学会雑誌, Sep. 2008, ,
|
191 | NASH起因発癌のエビデンス Nonalcoholic steatohepatitis(NASH)起因発癌におけるリスクファクターの検討, 肝臓, Sep. 2008, ,
|
192 | 大量デキサメサゾン負荷試験を契機に褐色細胞腫クリーゼとカテコラミン心筋症を誘発した両側副腎腫瘍の1例, 日本内科学会関東地方会, Jul. 2008, ,
|
193 | SLAIgG抗体陽性の自己免疫性肝炎にレボチロキシンナトリウムによる薬剤性肝障害を合併した1例, 日本内科学会関東地方会, Jun. 2008, ,
|
194 | SteviosideのC型肝炎に対する新規抗ウイルス薬としての可能性, 肝臓, Apr. 2008, ,
|
195 | 薬物性肝障害重症型の推移, 肝臓, Apr. 2008, ,
|
196 | B型慢性肝疾患に対するEntecavir単独療法及びAdefovir dipivoxilとの併用療法の有用性, 肝臓, Apr. 2008, ,
|
197 | 2度の下大静脈ステントが著効した進行性肝細胞癌による二次性Budd-Chiari syndromeの1例, 日本内科学会関東地方会, Mar. 2008, ,
|
198 | 原発性胆汁性肝硬変におけるHealth related quality of life(HRQOL), 日本内科学会雑誌, Feb. 2008, ,
|
199 | Zinc Dynamism in HCV replicon., , 2008, ,
|
200 | Possible role for human leukocyte antigen haplotypes in hepatotoxicity and/or pancreotoxicity associated with chemotherapy, , 2008, ,
|
201 | Health related quality of life in patients with primary biliary cirrhosis using a Japanese version of the PBC-40 questionnaire., , 2008, ,
|
202 | Stevioseide as a possible antiviral agent for hepatitis C virus infection., , 2008, ,
|
203 | Non Alcoholic fatty liver disease in Japanese patients with severe obesity who received laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in comparison to non-Japanese patients., , 2008, ,
|
204 | 非アルコール性脂肪性肝炎の病態における核内受容体CARの役割, 日本消化器病学会雑誌, Sep. 2007, ,
|
205 | VitaminE、K併用による肝癌抑制の検討, 肝臓, Sep. 2007, ,
|
206 | 塩酸チクロピジン(パナルジン)肝障害の素因について, The Kitakanto Medical Journal, Aug. 2007, ,
|
207 | 巨大副腎転移をきたしたNASH合併肝細胞癌の一例, The Kitakanto Medical Journal, May. 2007, ,
|
208 | ロキソプロフェンナトリウムによる重症薬物性肝障害の一例, The Kitakanto Medical Journal, May. 2007, ,
|
209 | 肝臓原発癌肉腫の一例, The Kitakanto Medical Journal, Feb. 2007, ,
|
210 | 当科における生体肝移植症例の検討, The Kitakanto Medical Journal, Feb. 2007, ,
|
211 | Clinical characteristics of null responders to Peg-IFN alpha 2b/Ribavirin therapy for chronic hepatitis C., , 2007, ,
|
212 | Peginterferon alpha-2a monotherapy for elderly patients with chronic hepatitis C., , 2007, ,
|
213 | Predictive factors of sustained virological response to peginterferon alpha-2a therapy in the patients with chronic hepatitis C despite the discontinuation of peginterferon alpha-2a therapy due to adverse events., , 2007, ,
|
214 | Incidence and risk factors for hepatic and extrehepatic malignancies in parimary biliary cirrhosis in Japan., , 2007, ,
|
215 | Preventive effects of vitamin K on recurrent disease in patientswith hepatocellar carcinoma arising from hepatitis C viral infection., , 2007, ,
|
216 | Overexpression of NK2 promotes liver fibrosis in carbon-tetrachloride-induced chronic liver injury., , 2007, ,
|
217 | 生体肝移植後のC型肝炎再発に対する治療, 移植, Oct. 2006, ,
|
218 | ロキソプロフェンナトリウムによる薬物性肝障害後に著明な好中球減少を合併した1例, 日本内科学会関東地方会, Oct. 2006, ,
|
219 | ダブルバルーン内視鏡が有用で、ステロイド及びシクロフォスファミドの併用療法が奏功したシェーグレン症候群に合併した蛋白漏出性胃腸症の一例, Gastroenterological Endoscopy, Sep. 2006, ,
|
220 | 興味ある症例の病理組織 右側大動脈弓を合併したびまん性肝血管奇形, 肝臓, Sep. 2006, ,
|
221 | C型肝炎の再燃・再発, The Kitakanto Medical Journal, Aug. 2006, ,
|
222 | 急速に進行する頸部腫脹により嗄声,呼吸困難を来した急性化膿性甲状腺炎の1例, 日本内科学会関東地方会, Jun. 2006, ,
|
223 | 肝細胞癌と肝内胆管癌の重複例の検討, 肝臓, Apr. 2006, ,
|
224 | C型慢性肝炎に対する亜鉛補充療法, 肝臓, Apr. 2006, ,
|
225 | C型慢性肝炎に対するPEG-IFN/Ribavirin併用療法におけるウイルス陰性化因子の検討, 日本消化器病学会雑誌, Mar. 2006, ,
|
226 | シェーグレン症候群に合併した蛋白漏出性胃腸症の1例, 日本内科学会関東地方会, Feb. 2006, ,
|
227 | Hepatic malignancies in patients with nonalcholic steatohepatitis, Los Angeles, USA, 2006, ,
|
228 | IFN著効後HCCを発症し,更にCCCを重複したと考えられた一例, The Kitakanto Medical Journal, Nov. 2005, ,
|
229 | 群馬県におけるC型肝炎ウイルス検診の現況と今後の課題, 日本消化器集団検診学会雑誌, Sep. 2005, ,
|
230 | B型慢性肝炎の治療方針の再検討 長期寛解を目指して Lamivudine(LAM)耐性株が出現したB型慢性肝疾患に対するAdefovir dipivoxil(ADV)単独療法の有用性, 日本消化器病学会雑誌, Sep. 2005, ,
|
231 | B型慢性肝炎の治療方針の再検討 長期寛解を目指して Lamivudine(LAM)耐性株が出現したB型慢性肝疾患に対するAdefovir dipivoxil(ADV)単独療法の有用性, 日本消化器集団検診学会雑誌, Sep. 2005, ,
|
232 | 高齢者C型肝炎患者に対するPegIFNalpha 2aの効果, 肝臓, Sep. 2005, ,
|
233 | B型慢性肝炎の治療方針の再検討 長期寛解を目指して Lamivudine(LAM)耐性株が出現したB型慢性肝疾患に対するAdefovir dipivoxil(ADV)単独療法の有用性, 肝臓, Sep. 2005, ,
|
234 | 5FU+IFNが著効し,現在追加IFN治療でHCV-RNAも消失しているC型肝硬変合併VP4肝癌の1例, The Kitakanto Medical Journal, Aug. 2005, ,
|
235 | 中心静脈カテーテル周囲血栓症の一例, The Kitakanto Medical Journal, Aug. 2005, ,
|
236 | 多発性単神経炎を呈した抗リン脂質抗体症候群を合併した全身性エリテマトーデス(SLE)の1例, 日本内科学会関東地方会, May. 2005, ,
|
237 | NASHの肝組織におけるhepatocyte growth factor(HGF)とHGF receptor(c-Met)proteinsの免疫組織染色による検討, 肝臓, May. 2005, ,
|
238 | 80歳以上高齢者肝癌の臨床的検討, 肝臓, May. 2005, ,
|
239 | 成人発症II型シトルリン血症患者肝組織のNASH類似性, 肝臓, May. 2005, ,
|
240 | Lamivudine(LAM)耐性株が出現したB型慢性肝疾患に対するAdefovir dipivoxil(ADV)単独療法の有用性, 日本消化器病学会雑誌, Mar. 2005, ,
|
241 | インターフェロン著効後に肝細胞癌を認めたC型慢性肝炎13例の臨床病理学的検討, 日本消化器病学会雑誌, Mar. 2005, ,
|
242 | 肝転移をきたした直腸カルチノイドの3例, 日本消化器病学会雑誌, Mar. 2005, ,
|
243 | 肝硬変患者における血中アディポネクチン濃度の検討, 日本内科学会雑誌, Feb. 2005, ,
|
244 | A Rondomized Controlled Trial of Consensus Intereron with or without Zinc for Chronic Hepatitis C Patients with Genotype 2, College's 70th Annual Scientific Meeting, 2005, ,
|
245 | 原発臓器不明で診断に苦慮した癌性腹膜炎の3例, 日本内科学会関東地方会, Dec. 2004, ,
|
246 | ラミブジン耐性HBVによるbreakthrough hepatitisにアデホビルを投与した治療困難であった1例, 肝臓, Nov. 2004, ,
|
247 | HBV重感染後のHCVウイルス減少期にIFN療法を施行し著効したIb高ウイルス量のC型慢性肝炎の1例, The Kitakanto Medical Journal, Nov. 2004, ,
|
248 | lamivudine耐性HBVによるbreakthrough hepatitisにAdefovirを投与し救命し得た1例, 日本内科学会関東地方会, Nov. 2004, ,
|
249 | 群馬県におけるC型肝炎検診の実態と今後の課題について, 肝臓, Sep. 2004, ,
|
250 | 肝細胞癌初回治療における肝切除とラジオ波焼灼療法の治療効果および肝予備能の検討, 肝臓, Sep. 2004, ,
|
251 | CA19-9異常高値を呈したbronchiolo alveolar cell Carcinoma(BAC)の1例, 日本内科学会関東地方会, Jun. 2004, ,
|
252 | 経皮的肝生検術における予防的抗菌療法, 肝臓, Apr. 2004, ,
|
253 | リザーバー肝動注化学療法が肝機能に及ぼす影響についての検討, 肝臓, Apr. 2004, ,
|
254 | 当科における生体肝移植ドナーの術後状態の検討, 日本消化器病学会雑誌, Mar. 2004, ,
|
255 | 肝移植後の血小板数の推移に関する検討, 日本消化器病学会雑誌, Mar. 2004, ,
|
256 | 2型糖尿病の経過中に診断されたNon-Alcoholic Steatohepatitis(NASH)とSmoldering Myelomaの一例, 日本内科学会関東地方会, Nov. 2003, ,
|
257 | 四塩化炭素投与による肝障害モデルにおけるHGF及びNK2の作用, The Kitakanto Medical Journal, Sep. 2001, ,
|
258 | αトコフェロールによる肝発癌抑制の試み, 肝臓, Sep. 2001, ,
|
259 | 四塩化炭素投与による肝障害モデルにおけるHGF及びNK2の作用, 肝臓, May. 2001, ,
|
260 | 門脈圧亢進症の内視鏡的治療 過去5年間の当科における内視鏡的食道静脈瘤治療成績, The Kitakanto Medical Journal, Sep. 2000, ,
|
261 | 性別にみる肝細胞癌の予後, 日本消化器病学会雑誌, Sep. 2000, ,
|
262 | 原発性胆汁性肝硬変症(PBC)の高齢患者における臨床的特徴, 肝臓, Sep. 2000, ,
|
263 | Group 1型C型慢性肝炎に対するInterferon-αとPolaprezincの併用療法 多施設間での成績, 肝臓, May. 2000, ,
|
264 | Hepatocyte growth factor(HGF)の自然変異体であるNK2のin vivoにおける機能の解析, 肝臓, May. 2000, ,
|
265 | TGFalphaトランスジェニックマウスの胃粘膜におけるEGF-リセプターの発現, 日本消化器病学会雑誌, Mar. 2000, ,
|
266 | TGF-αトランスジェニックマウスの酸化ストレスの肝発癌への関与とそのメカニズムの検討, 日本消化器病学会雑誌, Mar. 2000, ,
|
267 | 最近5年間の劇症肝炎例での肝移植適応例に関する検討, The Kitakanto Medical Journal, Feb. 2000, ,
|
268 | 原発性胆汁性肝硬変症(PBC)における予測予後の検討, 肝臓, Sep. 1999, ,
|
269 | 原発性胆汁性肝硬変患者の肝移植至適時期の検討, The Kitakanto Medical Journal, Jul. 1999, ,
|
270 | 生体肝移植施行例と肝移植未遂例の検討, The Kitakanto Medical Journal, Mar. 1999, ,
|
271 | TGF-αトランスジェニックマウス(MT42)を用いた肝発癌モデルにおけるα-tocopherolの予防効果についての検討, 日本消化器病学会雑誌, Mar. 1999, ,
|
272 | 等浸透圧状態におけるエタノールの好中球活性酸素産生能に及ぼす影響と好中球の細胞体積の変化との関係, 日本内科学会雑誌, Feb. 1999, ,
|
273 | C型慢性肝炎のIFN療法による組織学的変化についての検討 特に鉄染色について, 日本内科学会雑誌, Feb. 1999, ,
|
274 | 体質性ICG排泄異常症を合併した肝細胞癌の1例, 肝臓, Oct. 1998, ,
|
275 | ステロイドによるHBVキャリアのreactivationの検討, 肝臓, Oct. 1998, ,
|
276 | 群馬県地方における肝硬変の成因と臨床病理学的検討, 肝臓, Sep. 1998, ,
|
277 | 新犬山分類を用いたC型肝疾患における肝発癌とIFN治療の影響に関する検討 肝生検施行後長期経過観察例におけるretrospective study, 肝臓, Oct. 1996, ,
|
278 | C型慢性肝炎に対するIFN療法における有効例の検討 特に肝組織像の意義について, 日本消化器病学会雑誌, Aug. 1993, ,
|
279 | 異時性の食道癌を合併し化学療法が有効であった門脈本幹腫瘍栓を有する肝細胞癌の1例, 肝臓, Oct. 1992, ,
|
280 | HBs抗原陽性若年性肝硬変の2男性例, 肝臓, Oct. 1991, ,
|